KR102640760B1 - Manufacturing method of Medical Herb Tea - Google Patents
Manufacturing method of Medical Herb Tea Download PDFInfo
- Publication number
- KR102640760B1 KR102640760B1 KR1020210066909A KR20210066909A KR102640760B1 KR 102640760 B1 KR102640760 B1 KR 102640760B1 KR 1020210066909 A KR1020210066909 A KR 1020210066909A KR 20210066909 A KR20210066909 A KR 20210066909A KR 102640760 B1 KR102640760 B1 KR 102640760B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- parts
- hours
- prepared
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 53
- 240000007594 Oryza sativa Species 0.000 claims abstract description 27
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 27
- 235000009566 rice Nutrition 0.000 claims abstract description 27
- 235000015092 herbal tea Nutrition 0.000 claims abstract description 26
- 229940106587 pine bark extract Drugs 0.000 claims abstract description 23
- 235000020741 pine bark extract Nutrition 0.000 claims abstract description 23
- 229940023866 safflower seed extract Drugs 0.000 claims abstract description 23
- 239000008513 turmeric extract Substances 0.000 claims abstract description 23
- 229940052016 turmeric extract Drugs 0.000 claims abstract description 23
- 235000020240 turmeric extract Nutrition 0.000 claims abstract description 23
- 238000010438 heat treatment Methods 0.000 claims abstract description 21
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims abstract description 11
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960002442 glucosamine Drugs 0.000 claims abstract description 11
- 241001665715 Acanthophyllum Species 0.000 claims abstract description 10
- 102000004190 Enzymes Human genes 0.000 claims abstract description 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 6
- 241000122821 Aspergillus kawachii Species 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 89
- 244000179886 Moringa oleifera Species 0.000 claims description 24
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 18
- 244000163122 Curcuma domestica Species 0.000 claims description 16
- 241000132536 Cirsium Species 0.000 claims description 15
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 15
- 235000003373 curcuma longa Nutrition 0.000 claims description 15
- 235000013976 turmeric Nutrition 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 13
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 13
- 241000201895 Salicornia Species 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000000227 grinding Methods 0.000 claims description 12
- 238000010298 pulverizing process Methods 0.000 claims description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- 229940057059 monascus purpureus Drugs 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 8
- 244000020518 Carthamus tinctorius Species 0.000 claims description 8
- 239000001180 angelica archangelica l. root extract Substances 0.000 claims description 8
- 235000020687 goji berry extract Nutrition 0.000 claims description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 244000063299 Bacillus subtilis Species 0.000 claims description 6
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 240000002045 Guettarda speciosa Species 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 4
- 240000006079 Schisandra chinensis Species 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 229940124595 oriental medicine Drugs 0.000 claims description 4
- 235000010204 pine bark Nutrition 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000013616 tea Nutrition 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims 1
- 235000019640 taste Nutrition 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 6
- 238000012258 culturing Methods 0.000 abstract description 2
- 238000010025 steaming Methods 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 208000001132 Osteoporosis Diseases 0.000 description 9
- 230000037180 bone health Effects 0.000 description 8
- 241000233866 Fungi Species 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 235000010469 Glycine max Nutrition 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 235000008585 Pinus thunbergii Nutrition 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000011164 ossification Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 235000001270 Allium sibiricum Nutrition 0.000 description 3
- 235000005638 Austrian pine Nutrition 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 208000006386 Bone Resorption Diseases 0.000 description 3
- 241001632410 Eleutherococcus senticosus Species 0.000 description 3
- 241000218211 Maclura Species 0.000 description 3
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 3
- 235000008565 Pinus banksiana Nutrition 0.000 description 3
- 244000019397 Pinus jeffreyi Species 0.000 description 3
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 3
- 235000008578 Pinus strobus Nutrition 0.000 description 3
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000024279 bone resorption Effects 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 230000037231 joint health Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000003075 phytoestrogen Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 235000018865 Angelica gigas Nutrition 0.000 description 2
- 240000001810 Angelica gigas Species 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 206010065687 Bone loss Diseases 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- FFDULTAFAQRACT-MWBGVTEFSA-N Eleutheroside E Natural products COc1cc(cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H]3OC[C@H]4[C@H]3CO[C@@H]4c5cc(OC)c(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(OC)c5 FFDULTAFAQRACT-MWBGVTEFSA-N 0.000 description 2
- FFDULTAFAQRACT-JSGUJALWSA-N Eleutheroside E Chemical compound COC1=CC([C@@H]2[C@@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-JSGUJALWSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 2
- 235000002322 Monascus purpureus Nutrition 0.000 description 2
- 244000113306 Monascus purpureus Species 0.000 description 2
- 241000194105 Paenibacillus polymyxa Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000010072 bone remodeling Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- JIJQKFPGBBEJNF-UHFFFAOYSA-N curlone Chemical compound CC(C)=CC(=O)CC(C)C1CCC(=C)C=C1 JIJQKFPGBBEJNF-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 102000015694 estrogen receptors Human genes 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 239000001054 red pigment Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- NAAJVHHFAXWBOK-ZDUSSCGKSA-N (+)-(S)-ar-turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CC=C(C)C=C1 NAAJVHHFAXWBOK-ZDUSSCGKSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- CMJGAYUQSLJSCR-WACFDSSMSA-N (-)-Hibalactone Natural products C1=C2OCOC2=CC(/C=C2/[C@@H](CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-WACFDSSMSA-N 0.000 description 1
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- WTEXYKPGDKLLCW-KCSPPWDSSA-N (3Z,9aR)-3-(1-hydroxyhexylidene)-9a-methyl-6-[(E)-prop-1-enyl]furo[3,2-g]isoquinoline-2,9-dione Chemical compound CCCCC\C(O)=C1\C(=O)O[C@]2(C)C1=Cc1cc(\C=C\C)ncc1C2=O WTEXYKPGDKLLCW-KCSPPWDSSA-N 0.000 description 1
- AQTJNEHGKRUSLT-ODTNPMSZSA-N (3s,3ar,9ar)-9a-methyl-3-octanoyl-6-[(e)-prop-1-enyl]-3,3a,4,8-tetrahydrofuro[3,2-g]isochromene-2,9-dione Chemical compound C([C@@H]1[C@H](C(O[C@@]1(C)C1=O)=O)C(=O)CCCCCCC)C2=C1COC(\C=C\C)=C2 AQTJNEHGKRUSLT-ODTNPMSZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- JVLBOZIUMGNKQW-UHFFFAOYSA-N 1-hydroxy-3,4-seco-4(23),20(29)-lupadien-3,11-olid-28-oic acid 28-O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1C(CO)OC(OCC2C(C(O)C(O)C(OC(=O)C34C(C(CC3)C(C)=C)C3C(C5(C)CCC(C6(C)C(O)CC(=O)OC(C56)C3)C(C)=C)(C)CC4)O2)O)C(O)C1O JVLBOZIUMGNKQW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QZQXRZXYWVQWAY-UHFFFAOYSA-N 8-(9h-fluoren-9-ylmethoxycarbonylamino)octanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCCCCCCC(=O)O)C3=CC=CC=C3C2=C1 QZQXRZXYWVQWAY-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000167222 Acanthopanax sessiliflorus Species 0.000 description 1
- 241001143500 Aceraceae Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000219496 Alnus Species 0.000 description 1
- 241000544270 Angelica acutiloba Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193414 Bacillus fastidiosus Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000123667 Campanula Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- WIDAUXGFFXJZKU-HVLVMTFESA-N Chiisanoside Natural products C[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@]45CC[C@H]([C@@H]4[C@H]6C[C@H]7OC(=O)C[C@@H](O)[C@@H]8[C@@H](CC[C@](C)([C@H]78)[C@]6(C)CC5)C(=C)C)C(=C)C)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O WIDAUXGFFXJZKU-HVLVMTFESA-N 0.000 description 1
- 241000356311 Cirsium japonicum var. maackii Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- 229930153442 Curcuminoid Natural products 0.000 description 1
- JIJQKFPGBBEJNF-KBPBESRZSA-N Curlone Natural products CC(C)=CC(=O)C[C@H](C)[C@@H]1CCC(=C)C=C1 JIJQKFPGBBEJNF-KBPBESRZSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000007108 Fuchsia magellanica Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- CMJGAYUQSLJSCR-UUASQNMZSA-N Isohabilactone Natural products C1=C2OCOC2=CC(/C=C2/C(CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-UUASQNMZSA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 241001468192 Leuconostoc citreum Species 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- QCUYNKMUDZHGNK-UHFFFAOYSA-N Monascorubramine Natural products CCCCCCCC(=O)C1=C2C=C3C=C(NC=C3C(=O)C2(C)OC1=O)C=CC QCUYNKMUDZHGNK-UHFFFAOYSA-N 0.000 description 1
- 241001052469 Monascus kaoliang Species 0.000 description 1
- 241000030999 Monascus pilosus Species 0.000 description 1
- 241000031003 Monascus ruber Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000220214 Moringaceae Species 0.000 description 1
- 201000000023 Osteosclerosis Diseases 0.000 description 1
- 241000178961 Paenibacillus alvei Species 0.000 description 1
- 241000178959 Paenibacillus durus Species 0.000 description 1
- 241000178960 Paenibacillus macerans Species 0.000 description 1
- 241001310339 Paenibacillus popilliae Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000218686 Pinus thunbergii Species 0.000 description 1
- 244000171085 Polyporus umbellatus Species 0.000 description 1
- 235000004837 Polyporus umbellatus Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 244000305267 Quercus macrolepis Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000195473 Sargassum fulvellum Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000193395 Sporosarcina pasteurii Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 229930192007 acanthoside Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- ORJQJZWWJUNMQV-UHFFFAOYSA-N ankaflavin Natural products CCCCCCCC(=O)C1C2C=C3C=C(OC=C3C(=O)C2(C)OC1=O)C=CC ORJQJZWWJUNMQV-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- XOCANRBEOZQNAQ-KGLIPLIRSA-N ar-turmerone Natural products C[C@H](CC(=O)C=C(C)C)[C@@H]1CC=C(C)C=C1 XOCANRBEOZQNAQ-KGLIPLIRSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 1
- NRBFEAZFHRHFFQ-UHFFFAOYSA-N bisacumol Chemical compound CC(C)=CC(O)CC(C)C1=CC=C(C)C=C1 NRBFEAZFHRHFFQ-UHFFFAOYSA-N 0.000 description 1
- NRBFEAZFHRHFFQ-ZFWWWQNUSA-N bisacumol Natural products CC(C)=C[C@H](O)C[C@H](C)C1=CC=C(C)C=C1 NRBFEAZFHRHFFQ-ZFWWWQNUSA-N 0.000 description 1
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- JVLBOZIUMGNKQW-JBPVHNHLSA-N chiisanoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](OC(=O)[C@@]34[C@H]([C@@H](CC3)C(C)=C)[C@@H]3[C@@]([C@]5(C)CC[C@H]([C@]6(C)[C@H](O)CC(=O)O[C@@H]([C@@H]56)C3)C(C)=C)(C)CC4)O2)O)[C@H](O)[C@H]1O JVLBOZIUMGNKQW-JBPVHNHLSA-N 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000019503 curry powder Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000004821 effect on bone Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- -1 filter Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 description 1
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- CMJGAYUQSLJSCR-UHFFFAOYSA-N hibalactone Natural products C1=C2OCOC2=CC(C=C2C(CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 210000005067 joint tissue Anatomy 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- XXKNHBAFFJINCK-RVEJDSBJSA-N monascin Chemical compound C([C@@H]1[C@H](C(O[C@@]1(C)C1=O)=O)C(=O)CCCCC)C2=C1COC(\C=C\C)=C2 XXKNHBAFFJINCK-RVEJDSBJSA-N 0.000 description 1
- GFSMXLMQRWMHON-UHFFFAOYSA-N monascin Natural products CCCCCC(=O)C1C2C=C3C=C(OC=C3C(=O)C2(C)OC1=O)C=CC GFSMXLMQRWMHON-UHFFFAOYSA-N 0.000 description 1
- GIKQHOXMDCDAPT-UHFFFAOYSA-N monascusone B Natural products CC=CC1=CC2=C(CO1)C(=O)C3(C)OC(=O)C(C3C2)C(=O)C GIKQHOXMDCDAPT-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 239000000974 natural food coloring agent Substances 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- OVOAWDOEFJNCGI-UHFFFAOYSA-N rubropunctatamine Natural products CCCCCC(=O)C1=C2C=C3C=C(NC=C3C(=O)C2(C)OC1=O)C=CC OVOAWDOEFJNCGI-UHFFFAOYSA-N 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CMJGAYUQSLJSCR-ULIPXBITSA-N savinin Chemical compound C1=C2OCOC2=CC(\C=C2/[C@@H](CC=3C=C4OCOC4=CC=3)COC2=O)=C1 CMJGAYUQSLJSCR-ULIPXBITSA-N 0.000 description 1
- JGPMLTMSOKTANE-UHFFFAOYSA-N savinin Natural products O=C1OCC(/C/1=Cc2ccc3OCOc3c2)c4ccc5OCOc5c4 JGPMLTMSOKTANE-UHFFFAOYSA-N 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 231100001055 skeletal defect Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000006016 thyroid dysfunction Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- XOCANRBEOZQNAQ-UHFFFAOYSA-N α-turmerone Chemical compound CC(C)=CC(=O)CC(C)C1CC=C(C)C=C1 XOCANRBEOZQNAQ-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/08—Oxidation; Fermentation
- A23F3/10—Fermentation with addition of microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/18—Extraction of water soluble tea constituents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
- A23F3/26—Drying or concentrating tea extract by lyophilisation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
- A23F3/32—Agglomerating, flaking or tabletting or granulating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/41—Shearing
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법에 관한 것으로, 팽화미 30㎏에 물 60ℓ를 가하고 증자기를 이용하여 1.2㎏/㎠, 110℃에서 30분 동안 증자한 후, 백국균(Aspergillus Kawachii) 80g을 가하고 26℃의 항온항습기에서 40시간 동안 배양하여 입국을 제조하는 단계(단계 1); 상기 입국 4㎏, 물 6㎏ 및 효모 5g을 25~30℃에서 6일 동안 발효시켜 주모를 제조하는 단계(단계 2); 상기 주모 10㎏, 상기 입국 50㎏, 물 70㎏, 가시오가피추출물 1.0㎏, 홍화씨추출물 1.5㎏, 강황추출물 1.0㎏, 해송껍질추출물 1.0㎏ 및 글루코사민 0.5㎏을 22~23℃에서 6개월 동안 발효시켜 제1 사입을 얻는 단계(단계 3); 상기 제1 사입 130㎏, 팽화미 100㎏, 물 160㎏ 및 정제효소 150g을 15~16℃에서 3일 동안 발효시켜 제2 사입을 얻는 단계(단계 4); 및 상기 제2 사입을 100~105℃에서 30~40분 동안 가열하여 한방차를 제조하는 단계(단계 5); 를 포함하는 것을 기술적 특징으로 하며, 맛이 우수한 장점이 있다. The present invention relates to a method for manufacturing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract. Add 60 liters of water to 30 kg of puffed rice and boil at 1.2 kg/cm2 at 110°C for 30 minutes using a steamer. After steaming for a while, adding 80 g of Aspergillus Kawachii and culturing it in a constant temperature and humidity chamber at 26°C for 40 hours to prepare the rice (step 1); Producing the main hair by fermenting 4 kg of the rice, 6 kg of water, and 5 g of yeast at 25-30°C for 6 days (step 2); Prepared by fermenting 10 kg of the above-mentioned hair, 50 kg of the above-mentioned seedlings, 70 kg of water, 1.0 kg of Acanthopanax extract, 1.5 kg of safflower seed extract, 1.0 kg of turmeric extract, 1.0 kg of sea pine bark extract, and 0.5 kg of glucosamine at 22-23°C for 6 months. 1 Obtaining buy-in (step 3); Obtaining a second batch by fermenting 130 kg of the first batch, 100 kg of puffed rice, 160 kg of water, and 150 g of purified enzyme at 15-16°C for 3 days (step 4); and manufacturing oriental herbal tea by heating the second batch at 100-105°C for 30-40 minutes (step 5); It has technical features that include, and has the advantage of excellent taste.
Description
본 발명은 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법에 관한 것으로, 보다 상세하게는 맛이 우수한, 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법에 관한 것이다.The present invention relates to a method for producing an herbal tea containing Siberian ginseng extract, safflower seed extract, turmeric extract, and sea pine bark extract. More specifically, it relates to a method for producing a oriental herbal tea containing Siberian ginseng extract, safflower seed extract, turmeric extract, and sea pine bark extract, which have excellent taste. It is about the manufacturing method of herbal tea.
골조직은 골량(bone mass) 및 골격의 항상성(skeletal homeostasis)을 유지하기 위해 흡수와 형성이 끊임없이 일어나는 동적인 조직이다. 이러한 뼈의 재형성(bone remodeling)에는 두 종류의 특수한 기능을 하는 세포가 관여한다.Bone tissue is a dynamic tissue in which resorption and formation constantly occur to maintain bone mass and skeletal homeostasis. Two types of cells with special functions are involved in bone remodeling.
파골세포는 뼈를 흡수하는 반면, 조골세포는 뼈기질을 합성하고 채우는 역할을 한다. 따라서 골량은 이러한 세포의 상대적인 기능에 의존하게 된다. 정상 성인에서는 골흡수 양과 골형성 양 사이에는 항상 균형이 유지되고 있다.Osteoclasts resorb bone, while osteoblasts synthesize and fill bone matrix. Therefore, bone mass depends on the relative functions of these cells. In normal adults, a balance is always maintained between the amount of bone resorption and the amount of bone formation.
골개조는 일정한 주기를 통해 일어나며 국소적으로 좁은 부위에서 일어남으로써 골격계의 구조가 유지되는데 이러한 골격계의 구조와 기능은 전신적인 호르몬과 국소적 인자 사이의 복잡한 상호작 용에 의해 조절된다Bone remodeling occurs through regular cycles and occurs locally in small areas to maintain the structure of the skeletal system. The structure and function of the skeletal system are regulated by complex interactions between systemic hormones and local factors.
조골세포와 파골세포 활성간의 불균형은 전체적인 뼈의 감소(osteoporosis) 나 증가(osteosclerosis)로 인한 골격의 이상으로 나타난다. 이러한 골대사 불균형은 일차적으로 조골세포의 기능저하에 의한 것인지, 혹은 골흡수의 증가 즉, 파골세포의 활성도 강화에 의한 것인지에 대하여는 여러 가지 이론과 주장이 제기되고 있으며 골다공증의 요인으로는 연령의 증가, 영양 결핍, 운동부족, 칼슘 섭취의 부족, 유전적 요소, 약물복용, 호르몬의 영향 등을 꼽는다.An imbalance between osteoblast and osteoclast activity results in skeletal abnormalities resulting from overall bone loss (osteoporosis) or gain (osteosclerosis). Various theories and claims have been raised as to whether this imbalance in bone metabolism is primarily caused by decreased function of osteoblasts or by increased bone resorption, that is, enhanced activity of osteoclasts. Factors for osteoporosis include increased age and poor nutrition. Factors such as deficiency, lack of exercise, insufficient calcium intake, genetic factors, medication use, and hormonal effects are cited.
골대사 질환 중 고령사회에서 큰 문제로 대두되고 있는 골다공증은 골의 화학적 조성에는 큰 변화 없이 단위 용적내의 골량이 감소하여 경미한 충격에도 쉽게 골절을 일으킬 수 있는 질환이다. 노인 특히 폐경 후 여성들의 경우 에스트로겐(estrogen)의 분비부족으로 인하여 가장 그 발생 빈도가 높게 나타난다고 알려져 있다. 그러나, 남성이라도 노화에 따라 골질량이 감소하는 경향이 나타나며 최근 20년간 초·중학생의 골절률은 2배 이상 증가하고 있는 실정이다. 골 대사 불균형으로 인한 골질환의 예방 또는 치료 측면에서, 젊은 때부터 골질량을 높이는 것이 상당히 중요하며, 이와 같이 뼈의 건강을 유지하는 것은 성별이나 연령과 관계없이 중요한 문제이다.Among bone metabolic diseases, osteoporosis, which has emerged as a major problem in the aging society, is a disease that can easily cause fractures even with minor impacts due to a decrease in bone mass per unit volume without significant changes in the chemical composition of bone. It is known that elderly people, especially postmenopausal women, have the highest incidence due to insufficient secretion of estrogen. However, even in men, bone mass tends to decrease with aging, and the fracture rate among elementary and middle school students has more than doubled over the past 20 years. In terms of preventing or treating bone diseases caused by bone metabolic imbalance, it is very important to increase bone mass from a young age, and maintaining bone health is an important issue regardless of gender or age.
현재 골다공증 예방 및 치료에 사용되고 있는 약제는 대부분 골흡수를 억제하는 작용을 하기 때문에 이미 진행된 골소실을 완전히 회복할 수 없으며, 따라서 궁극적인 목표인 골다공증의 발생을 완전히 예방할 수 없는 현실이다. 이에 골다공증의 예방과 치료를 위해 골형성 증가에 관한 연구가 최근 주목받고 있으며 골조직 재생능력에 미치는 영향 등에 대한 과학적인 접근이 필요한 실정이다Most of the drugs currently used to prevent and treat osteoporosis act to inhibit bone resorption, so they cannot completely restore bone loss that has already progressed, and therefore cannot completely prevent the occurrence of osteoporosis, which is the ultimate goal. Accordingly, research on increasing bone formation for the prevention and treatment of osteoporosis has recently received attention, and a scientific approach to the effect on bone tissue regeneration ability is needed.
따라서, 뼈 파괴세포의 활성 억제, 뼈 형성 세포의 활성화를 통한 골 형성 촉진 효과가 우수하여 골다공증의 발생을 예방하고, 억제할 수 있는 뼈 건강 개선용 조성물에 대한 개발이 필요한 실정이다.Therefore, there is a need to develop a composition for improving bone health that can prevent and suppress the occurrence of osteoporosis by suppressing the activity of bone destruction cells and promoting bone formation through activation of bone forming cells.
대한민국공개특허공보 제10-2021-0054179호(2021.05.13.)에 두메부추 추출물을 유효성분으로 함유하는 뼈 건강 개선용 조성물이 개시되어 있다.Republic of Korea Patent Publication No. 10-2021-0054179 (2021.05.13.) discloses a composition for improving bone health containing Dume chive extract as an active ingredient.
상기 두메부추 추출물을 유효성분으로 함유하는 뼈 건강 개선용 조성물은 부작용이 적은 장점이 있지만, 뼈 건강 개선 효과가 미흡한 단점이 있다.The composition for improving bone health containing the above-mentioned chive extract as an active ingredient has the advantage of having fewer side effects, but has the disadvantage of being insufficient in improving bone health.
본 발명의 목적은 맛이 우수한, 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법을 제공하는 것이다.The purpose of the present invention is to provide a method for producing an herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract, which has excellent taste.
삭제delete
상기 목적을 달성하기 위하여 본 발명은 다음과 같은 수단을 제공한다.In order to achieve the above object, the present invention provides the following means.
본 발명은, 팽화미 30㎏에 물 60ℓ를 가하고 증자기를 이용하여 1.2㎏/㎠, 110℃에서 30분 동안 증자한 후, 백국균(Aspergillus Kawachii) 80g을 가하고 26℃의 항온항습기에서 40시간 동안 배양하여 입국을 제조하는 단계(단계 1); 상기 입국 4㎏, 물 6㎏ 및 효모 5g을 25~30℃에서 6일 동안 발효시켜 주모를 제조하는 단계(단계 2); 상기 주모 10㎏, 상기 입국 50㎏, 물 70㎏, 가시오가피추출물 1.0㎏, 홍화씨추출물 1.5㎏, 강황추출물 1.0㎏, 해송껍질추출물 1.0㎏ 및 글루코사민 0.5㎏을 22~23℃에서 6개월 동안 발효시켜 제1 사입을 얻는 단계(단계 3); 상기 제1 사입 130㎏, 팽화미 100㎏, 물 160㎏ 및 정제효소 150g을 15~16℃에서 3일 동안 발효시켜 제2 사입을 얻는 단계(단계 4); 및 상기 제2 사입을 100~105℃에서 30~40분 동안 가열하여 한방차를 제조하는 단계(단계 5); 를 포함하는, 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법을 제공한다.In the present invention, 60 liters of water is added to 30 kg of puffed rice, steamed at 1.2 kg/cm2 and 110°C for 30 minutes using a steamer, then 80g of Aspergillus Kawachii is added and steamed in a constant temperature and humidity chamber at 26°C for 40 hours. Manufacturing the entry by culturing (step 1); Producing the main hair by fermenting 4 kg of the rice, 6 kg of water, and 5 g of yeast at 25-30°C for 6 days (step 2); Prepared by fermenting 10 kg of the above-mentioned hair, 50 kg of the above-mentioned seedlings, 70 kg of water, 1.0 kg of Acanthopanax extract, 1.5 kg of safflower seed extract, 1.0 kg of turmeric extract, 1.0 kg of sea pine bark extract, and 0.5 kg of glucosamine at 22-23°C for 6 months. 1 Obtaining buy-in (step 3); Obtaining a second batch by fermenting 130 kg of the first batch, 100 kg of puffed rice, 160 kg of water, and 150 g of purified enzyme at 15-16°C for 3 days (step 4); and manufacturing oriental herbal tea by heating the second batch at 100-105°C for 30-40 minutes (step 5); It provides a method for producing an herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract.
상기 단계 1에서, 상기 팽화미는 멥쌀 30㎏ 및 물 30㎏을 혼합하여 내부온도가 100℃인 압력가열기에서 10분 동안 가열하고, 15℃ 및 120Pa 압력 하의 진공건조기에서 건조시킨 뒤, 100~150메쉬로 분쇄하여 제조한다.In Step 1, the puffed rice is mixed with 30 kg of non-glutinous rice and 30 kg of water, heated for 10 minutes in a pressure heater with an internal temperature of 100 ° C., dried in a vacuum dryer at 15 ° C. and 120 Pa pressure, and then dried in a vacuum dryer of 100 to 150 mesh. It is manufactured by grinding.
상기 단계 3에서, 상기 가시오가피추출물은 가시오가피 10㎏을 함초수 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물을 초임계 추출기의 반응기에 투입하고 CO2 gas를 주입하면서 반응기를 회전시키고, 반응기 내 압력을 60기압으로 유지하면 CO2를 순환시켜 얻은 추출물을 여과하고 동결건조한 후 분말화하여 제조하며, 상기 함초수는 함초 80중량%, 매실 15중량% 및 오미자 5중량%를 혼합한 혼합물 100중량부에 물 1,000중량부를 가하고 100~105℃에서 4~6시간 동안 가열한 후 여과하여 제조하며, 상기 홍화씨추출물은 홍화씨 10㎏을 구기자추출액 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물 100중량부에 80%(v/v) 에탄올 200중량부를 가하고 4시간씩 3회 환류추출하고 냉침한 후 여과하고 동결건조한 후 분말화하여 제조하며, 상기 구기자추출액은 구기자 100중량부에 물 300~400중량부를 가하고 95~105℃에서 1~2시간 동안 가열한 후 여과하여 제조하며, 상기 강황추출물은 강황을 60℃에서 건조시킨 후 분쇄기로 분쇄하여 강황 분말을 제조한 후, 상기 강황분말 100중량부에 95%(v/v) 에탄올 300중량부를 가하고 75℃에서 3시간 동안 3회 반복하여 교반하면서 환류추출한 후 여과하고 동결건조한 후 분말화하여 제조하며, 상기 해송껍질추출물은 해송껍질 200g에 70%(v/v) 에탄올 1.2 ℓ를 가하고 5일 동안 침지하여 유효성분을 추출하고 여과한 후 냉각 콘덴서가 장치된 추출기에서 5시간 동안 70~90℃에서 가열하여 농축한 후 분말화하여 제조한다. In step 3, the Acanthopanax extract is prepared by immersing 10 kg of Acanthopanax in 20 liters of Salicornia water for 12 hours, drying and pulverizing the pulverized material, putting the pulverized material into the reactor of a supercritical extractor and rotating the reactor while injecting CO 2 gas. When the pressure in the reactor is maintained at 60 atmospheres, the extract obtained by circulating CO 2 is filtered, freeze-dried, and powdered to prepare the salicornia water, which is a mixture of 80% by weight of salicornia, 15% by weight of plum, and 5% by weight of Schisandra chinensis. It is prepared by adding 1,000 parts by weight of water to 100 parts by weight of the mixture, heating at 100-105°C for 4-6 hours, and then filtering. The safflower seed extract is prepared by soaking 10 kg of safflower seeds in 20 liters of goji berry extract for 12 hours, then drying and grinding. Then, 200 parts by weight of 80% (v/v) ethanol was added to 100 parts by weight of the pulverized material, extracted under reflux three times for 4 hours each, cold soaked, filtered, freeze-dried, and powdered. The Goji berry extract was prepared by mixing 100 parts by weight of Goji berry It is prepared by adding 300 to 400 parts by weight of water, heating at 95 to 105°C for 1 to 2 hours, and then filtering. The turmeric extract is prepared by drying turmeric at 60°C and pulverizing it with a grinder to produce turmeric powder. , 300 parts by weight of 95% (v/v) ethanol is added to 100 parts by weight of the turmeric powder, refluxed and extracted with repeated stirring at 75° C. for 3 hours, filtered, freeze-dried, and powdered, and the sea pine bark extract is prepared. Add 1.2 liters of 70% (v/v) ethanol to 200 g of sea pine bark, soak for 5 days to extract the active ingredients, filter, and concentrate by heating at 70-90°C for 5 hours in an extractor equipped with a cooling condenser. It is manufactured by powdering.
상기 단계 4 이후에, 상기 제2 사입 100중량부에 모자반추출물 1~3중량부, 엉겅퀴추출물 1~3중량부 및 참당귀추출물 1~3중량부를 추가적으로 포함하되, 상기 모자반추출물은 모자반 100g에 2ℓ의 30%(v/v) 에탄올 수용액에 넣고 25℃에서 24시간 동안 추출하여 제조하며, 상기 엉겅퀴추출물은 엉겅퀴 뿌리 100g에 2ℓ의 50%(v/v) 에탄올 수용액에 넣고 35℃에서 24시간 동안 추출하여 제조하며, 상기 참당귀추출물은 참당귀 뿌리 100g에 2ℓ의 70%(v/v) 에탄올 수용액에 넣고 40℃에서 24시간 동안 추출하여 제조한다. After step 4, 100 parts by weight of the second injection additionally includes 1 to 3 parts by weight of moss extract, 1 to 3 parts by weight of thistle extract, and 1 to 3 parts by weight of angelica root extract, wherein the moss extract is 2 liters per 100 g of moss. It is prepared by placing it in a 30% (v/v) ethanol aqueous solution and extracting it at 25°C for 24 hours. The thistle extract is prepared by adding 100 g of thistle root to 2 liters of a 50% (v/v) ethanol aqueous solution and extracting it at 35°C for 24 hours. It is manufactured by extraction, and the Angelica root extract is prepared by adding 100 g of Angelica root to 2 liters of 70% (v/v) ethanol aqueous solution and extracting at 40°C for 24 hours.
상기 단계 5 이후에, 상기 한방차 100중량부에 모링가 추출발효물 0.1~1중량부, 저령 추출발효물 0.1~1중량부 및 꾸지뽕청 0.1~1중량부를 추가적으로 포함하되, 상기 모링가 추출발효물은 모링가잎 100중량부에 80%(v/v) 에탄올 300~400중량부를 넣고 14~16시간 초음파 추출한 모링가잎 추출액 100중량부에 황국균 1~3중량부를 첨가하고 15~20℃에서 30~32시간 동안 발효시켜 제조하며, 상기 저령 추출발효물은 저령 100중량부에 70%(v/v) 에탄올 600~700중량부를 넣고 65~70℃에서 24~25시간 동안 추출한 저령 추출액 100중량부에 혼합균 1~3중량부를 첨가하고 15~20℃에서 14~15시간 동안 발효시켜 제조하며, 상기 혼합균은 유산균 60~70중량%, 홍국균 20~30중량% 및 고초균 5~15중량%를 포함하며, 상기 꾸지뽕청은 꾸지뽕 열매 100중량부에 물 800~900중량부를 가하고 100~105℃에서 4~6시간 동안 추출한 후 50~60℃에서 저온진공 농축하여 70~75Brix의 꾸지뽕 농축액을 제조한 후, 70~75℃에서 25~30분 동안 가열하여 제조한다.After step 5, 100 parts by weight of the oriental tea additionally includes 0.1 to 1 part by weight of Moringa extract fermentation material, 0.1 to 1 part by weight of low age extract fermentation material, and 0.1 to 1 part by weight of kkujippong extract, wherein the Moringa extract fermentation For water, add 300 to 400 parts by weight of 80% (v/v) ethanol to 100 parts by weight of Moringa leaves, add 1 to 3 parts by weight of Chrysanthemum aureus to 100 parts by weight of Moringa leaf extract extracted ultrasonically for 14 to 16 hours, and mix at 15 to 20°C. It is manufactured by fermentation for 30-32 hours, and the fermented low-age extract is 100 parts by weight of low-age extract extracted by adding 600-700 parts by weight of 70% (v/v) ethanol to 100 parts by weight of low-age extract and extracting it for 24-25 hours at 65-70°C. It is manufactured by adding 1 to 3 parts by weight of mixed bacteria and fermenting at 15 to 20 ℃ for 14 to 15 hours, and the mixed bacteria contains 60 to 70% by weight of lactic acid bacteria, 20 to 30% by weight of Red Yeast bacteria, and 5 to 15% by weight of Bacillus subtilis. It includes, the kkujippong extract is prepared by adding 800 to 900 parts by weight of water to 100 parts by weight of kkujippong fruit, extracting it at 100 to 105 ℃ for 4 to 6 hours, and then concentrating in low temperature vacuum at 50 to 60 ℃ to prepare a kkujippong concentrate of 70 to 75 Brix. Then, it is prepared by heating at 70-75°C for 25-30 minutes.
본 발명에 따른 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법은 맛이 우수한 장점이 있다.The method for producing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract according to the present invention has the advantage of excellent taste.
삭제delete
이하, 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail as follows.
먼저, 본 발명에 따른 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법을 설명한다.First, a method for producing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract according to the present invention will be described.
본 발명의 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법은,The method for producing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract of the present invention,
팽화미 30㎏에 물 60ℓ를 가하고 증자기를 이용하여 1.2㎏/㎠, 110℃에서 30분 동안 증자한 후, 백국균(Aspergillus Kawachii) 80g을 가하고 26℃의 항온항습기에서 40시간 동안 배양하여 입국을 제조하는 단계(단계 1);Add 60 liters of water to 30 kg of puffed rice and steam it for 30 minutes at 110°C at 1.2 kg/cm2 using a steamer, then add 80 g of Aspergillus Kawachii and culture in a constant temperature and humidity chamber at 26°C for 40 hours before entering the country. manufacturing step (step 1);
상기 입국 4㎏, 물 6㎏ 및 효모 5g을 25~30℃에서 6일 동안 발효시켜 주모를 제조하는 단계(단계 2);Producing the main hair by fermenting 4 kg of the rice, 6 kg of water, and 5 g of yeast at 25-30°C for 6 days (step 2);
상기 주모 10㎏, 상기 입국 50㎏, 물 70㎏, 가시오가피추출물 1.0㎏, 홍화씨추출물 1.5㎏, 강황추출물 1.0㎏, 해송껍질추출물 1.0㎏ 및 글루코사민 0.5㎏을 22~23℃에서 6개월 동안 발효시켜 제1 사입을 얻는 단계(단계 3);Prepared by fermenting 10 kg of the above-mentioned hair, 50 kg of the above-mentioned seedlings, 70 kg of water, 1.0 kg of Acanthopanax extract, 1.5 kg of safflower seed extract, 1.0 kg of turmeric extract, 1.0 kg of sea pine bark extract, and 0.5 kg of glucosamine at 22-23°C for 6 months. 1 Obtaining buy-in (step 3);
상기 제1 사입 130㎏, 팽화미 100㎏, 물 160㎏ 및 정제효소 150g을 15~16℃에서 3일 동안 발효시켜 제2 사입을 얻는 단계(단계 4); 및Obtaining a second batch by fermenting 130 kg of the first batch, 100 kg of puffed rice, 160 kg of water, and 150 g of purified enzyme at 15-16°C for 3 days (step 4); and
상기 제2 사입을 100~105℃에서 30~40분 동안 가열하여 한방차를 제조하는 단계(단계 5);Preparing oriental medicine tea by heating the second batch at 100-105°C for 30-40 minutes (step 5);
를 포함한다.Includes.
상기 단계 1에서, 상기 팽화미는 멥쌀 30㎏ 및 물 30㎏을 혼합하여 내부온도가 100℃인 압력가열기에서 10분 동안 가열하고, 15℃ 및 120Pa 압력 하의 진공건조기에서 건조시킨 뒤, 100~150메쉬로 분쇄하여 제조한다.In Step 1, the puffed rice is mixed with 30 kg of non-glutinous rice and 30 kg of water, heated for 10 minutes in a pressure heater with an internal temperature of 100 ° C., dried in a vacuum dryer at 15 ° C. and 120 Pa pressure, and then dried in a vacuum dryer of 100 to 150 mesh. It is manufactured by grinding.
상기 단계 3은 상기 주모 10㎏, 상기 입국 50㎏, 물 70㎏, 가시오가피추출물 1.0㎏, 홍화씨추출물 1.5㎏, 강황추출물 1.0㎏, 해송껍질추출물 1.0㎏ 및 글루코사민 0.5㎏을 22~23℃에서 6개월 동안 발효시켜 제1 사입을 얻는 단계이다.In step 3, 10 kg of hair, 50 kg of raw material, 70 kg of water, 1.0 kg of Acanthopanax extract, 1.5 kg of safflower seed extract, 1.0 kg of turmeric extract, 1.0 kg of sea pine bark extract, and 0.5 kg of glucosamine were incubated at 22-23°C for 6 months. This is the stage of obtaining the first stock through fermentation.
본 발명은, 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 6개월 동안 발효시킴으로써 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물의 약효 성분을 현저히 용출할 수 있는 장점이 있다.The present invention has the advantage of significantly eluting the medicinal ingredients of the Acanthopanax extract, safflower seed extract, turmeric extract, and sea pine bark extract by fermenting them for 6 months.
상기 가시오가피(Acanthopanax senticosus) 및 오가피(A. sessiliflorus)는 두릅나무과(Araliaceae)에 속하는 오가피속(Acanthopanax) 식물로 낙엽활엽 관목으로, 키는 3~4cm이고 뿌리 근처에서 가지가 많이 갈라져 사방으로 퍼지며 잎은 호생하고 장상복엽이며 소엽은 3~5개로 난형이다.The Acanthopanax senticosus and A. sessiliflorus are plants of the genus Acanthopanax belonging to the Araliaceae family and are deciduous broad-leaved shrubs with a height of 3 to 4 cm, many branches branched near the roots, and leaves spread in all directions. It is alternate, has long compound leaves, and has 3 to 5 leaflets, which are egg-shaped.
오가피속 식물은 동의보감을 위시한 한약집성방, 신농본초경 및 본초강목에 이르기까지 고전 한의서에 그 약리효능이 탁월한 것으로 기재되어, 강장제로서 기관지 천식 치료, 육체력 증진, 근골격 증진, 신경통, 당뇨 등의 효과가 알려져 있으며, 최근에 들어서는 혈압강하작용, 간기능 보호작용, 조혈촉진 및 면역기능 증진작용, 혈중 콜레스테롤 저하작용, 항산화작용, 항알러지작용 및 항암작용 등을 가지는 것으로 과학적으로 규명되어, 건강기능성 식품을 포함한 여러 분야에서 관심과 사용이 증가하는 추세에 있다.Plants of the genus Pseudomonas are described as having excellent pharmacological effects in classical Oriental medicine, including Donguibogam, herbal medicine compilation, Shennong herbal medicine, and herbal medicine, and as a tonic, they are effective in treating bronchial asthma, improving physical strength, musculoskeletal improvement, neuralgia, and diabetes. It is known to have a blood pressure lowering effect, liver function protection effect, hematopoiesis promotion and immune function enhancement effect, blood cholesterol lowering effect, antioxidant effect, anti-allergy effect, and anti-cancer effect, and has recently been scientifically identified as a health functional food. Interest and use are increasing in many fields, including:
상술한 효과를 나타내는 오가피속 식물 중에서 가시오가피는 세사민(sesamin) 및 사비닌(savinin)을 비롯하여 리그닌(lignan)의 배당체인 아칸토시드(acanthoside) A, B, C, D와 키사노시드(chiisanoside), 폴리아세틸렌(polyacetylene), β-시토스테롤(β-sitosterol), 캄페스테롤(campesterol), 비타민, 미네랄 등이 풍부하여 좋은 약재로 주목받고 있으며, 특히, 우수한 효능을 나타내는 아칸토시드-D에 대하여는 많은 연구가 진행되고 있다. 아칸토시드-D의 주요 효능으로는 T세포 증가 작용, 콜레스테롤 수치 저하, 전립선 활성, 정력증대, 학습력 향상, 간기능 개선, 위궤양 억제, 생체활력지수와 면역기능 증진 및 백혈병 억제작용 등에 효능이 있는 것으로 알려져 있다. 아칸토시드-D의 화학적 구조식은 C34H46O18로서, 녹는 점은 242℃이고 엘루테로시드(eleutheroside) E로 지칭되고 있으며, 가시오가피의 자생지, 재배기간, 부위 또는 시료의 직경 등 크기에 따라 엘루테로시드 E 성분의 차이가 현저한 것으로 보고되어 있어, 이러한 가시오가피를 효과적으로 이용하기 위한 다양한 연구가 진행되고 있는 실정이다.Among the plants of the genus Acanthopanax that exhibit the above-mentioned effects, Acanthopanax contains sesamin and savinin, as well as acanthoside A, B, C, D, which is a glycoside of lignan, and chiisanoside. , polyacetylene, β-sitosterol, campesterol, vitamins, minerals, etc., it is rich in vitamins and minerals, so it is attracting attention as a good herbal medicine. In particular, acantoside-D, which shows excellent efficacy, is widely known. Research is in progress. The main effects of acantoside-D include increasing T cells, lowering cholesterol levels, activating the prostate, increasing stamina, improving learning ability, improving liver function, suppressing stomach ulcers, improving vitality index and immune function, and suppressing leukemia. It is known that The chemical structural formula of acantoside-D is C 34 H 46 O 18 , and its melting point is 242°C. It is referred to as eleutheroside E, and its size varies depending on the size of the plant, such as its native habitat, cultivation period, area, or sample diameter. Accordingly, it has been reported that there is a significant difference in the eleutheroside E component, and various studies are being conducted to effectively use this plant.
상기 가시오가피추출물은 가시오가피 10㎏을 함초수 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물을 초임계 추출기의 반응기에 투입하고 CO2 gas를 주입하면서 반응기를 회전시키고, 반응기 내 압력을 60기압으로 유지하면 CO2를 순환시켜 얻은 추출물을 여과하고 동결건조한 후 분말화한다.The Acanthopanax extract is prepared by immersing 10 kg of Acanthopanax in 20 liters of salicornia water for 12 hours, drying and pulverizing the pulverized product, putting the pulverized material into the reactor of a supercritical extractor, rotating the reactor while injecting CO 2 gas, and maintaining the pressure in the reactor. When the pressure is maintained at 60 atmospheres, the extract obtained by circulating CO 2 is filtered, freeze-dried, and powdered.
상기 함초수는 함초 80중량%, 매실 15중량% 및 오미자 5중량%를 혼합한 혼합물 100중량부에 물 1,000중량부를 가하고 100~105℃에서 4~6시간 동안 가열한 후 여과하여 제조한다. The salicornia water is prepared by adding 1,000 parts by weight of water to 100 parts by weight of a mixture of 80% by weight of salicornia, 15% by weight of plum, and 5% by weight of Schisandra chinensis, heated at 100-105°C for 4-6 hours, and then filtered.
홍화(Safflower, Carthamus tinctorious L.)는 국화과에 속하는 일년생 초목으로 원산지는 아프가니스탄의 산악지대 또는 에티오피아이며 중국, 티벳 등지에서 재배된다. 홍화의 약용 부위로는 꽃과 씨가 있으며 혈소판 응고를 억제시키고 출혈시간을 지연시킬 뿐만 아니라 혈장 콜레스테롤과 중성지방을 저하시키는 작용도 한다. 특히, 홍화씨유에는 리놀레산을 비롯한 다량의 불포화지방산과 토코페롤을 함유하고 있어 항산화, 항혈전 및 항고혈압성 신소재로서 이용되고 있으며 이를 위해 볶은 홍화씨를 착유하여 식용유로서 사용하고 있다. Safflower ( Carthamus tinctorious L.) is an annual plant belonging to the Asteraceae family. Its origin is the mountainous regions of Afghanistan or Ethiopia, and it is cultivated in China, Tibet, etc. The medicinal parts of safflower include flowers and seeds, which not only inhibit platelet coagulation and delay bleeding time, but also lower plasma cholesterol and triglycerides. In particular, safflower seed oil contains a large amount of unsaturated fatty acids and tocopherol, including linoleic acid, and is used as a new material with antioxidant, anti-thrombotic and anti-hypertensive properties. For this purpose, roasted safflower seeds are extracted and used as cooking oil.
또한, 홍화씨는 세로토닌, 리그난 및 플라보노이드와 같은 페놀화합물을 함유하고 있어 강한 항산화, 항고지혈증 효과를 가지고 있으며 특히 에스트로겐 유사활성을 지니고 있는 피토에스트로겐 성분으로서 기존의 피토에스트로겐 화합물로 알려진 성분과 유사하게 뼈 형성을 촉진함으로써 갱년기 여성의 골다공증을 예방하고 골결손시 신생골을 형성시킬 수 있다. In addition, safflower seeds contain phenolic compounds such as serotonin, lignans, and flavonoids, which have strong antioxidant and antihyperlipidemic effects. In particular, they are phytoestrogen components with estrogen-like activity, which promote bone formation similar to components known as existing phytoestrogen compounds. By promoting , it can prevent osteoporosis in menopausal women and form new bone in case of bone defect.
상기 홍화씨추출물은 홍화씨 10㎏을 구기자추출액 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물 100중량부에 80%(v/v) 에탄올 200중량부를 가하고 4시간씩 3회 환류추출하고 냉침한 후 여과하고 동결건조한 후 분말화한다.The safflower seed extract was prepared by soaking 10 kg of safflower seeds in 20 liters of goji berry extract for 12 hours, drying and pulverizing, adding 200 parts by weight of 80% (v/v) ethanol to 100 parts by weight of the pulverized material, and extracting under reflux three times for 4 hours each. After soaking in cold water, it is filtered, freeze-dried, and powdered.
상기 구기자추출액은 구기자 100중량부에 물 300~400중량부를 가하고 95~105℃에서 1~2시간 동안 가열한 후 여과하여 제조하였다.The goji berry extract was prepared by adding 300 to 400 parts by weight of water to 100 parts by weight of goji berries, heating at 95 to 105°C for 1 to 2 hours, and then filtering.
강황은 생강목 생강과에 속하는 다년생 식물로서 인도를 중심으로 한 열대, 아열대 지역에서 주로 재배되며 줄기와 뿌리를 식용, 약용 등으로 사용한다. 인도, 중국, 동남아시아 등지에서 많이 재배되며, 우리나라는 전남 진도, 전남 해남, 전북 부안, 경기 시흥, 충남 청양 등지에서 재배되고 있다. 꽃 이삭은 잎 보다 먼저 나오고 넓은 달걀 모양이며 연한 녹색의 포에 싸여 있다. 4∼6월에 잎겨드랑이에서 노란 꽃이 핀다. 윗부분의 포는 나비가 약간 좁고 끝은 담자홍색이며 잎겨드랑이에 꽃이 달리지 않는다. 뿌리줄기의 겉은 연한 노랑색이고, 속은 주홍빛으로 장뇌 같은 향기가 난다. 강황은 뿌리줄기를 한약재로 사용한다. 맵고 쓴 맛이 나는 황색의 약재로, 항암, 알츠하이머 치료, 항산화, 항염증, 해독, 간 장애 억제, 통증완화, 월경불순 등에 효능이 있다. 인도에서는 타박상이나 염좌에 바르는 약으로 쓰며 카레 가루의 향신료로 쓰기도 한다.Turmeric is a perennial plant belonging to the ginger family. It is mainly cultivated in tropical and subtropical regions, mainly in India, and its stems and roots are used for edible and medicinal purposes. It is widely cultivated in India, China, and Southeast Asia, and in Korea, it is cultivated in places such as Jindo in Jeollanam-do, Haenam in Jeonnam, Buan in Jeollabuk-do, Siheung in Gyeonggi-do, and Cheongyang in South Chungcheong. The flower spikes emerge before the leaves, are broadly egg-shaped, and are wrapped in light green bracts. Yellow flowers bloom from the leaf axils from April to June. The bracts in the upper part are slightly narrow, the tips are fuchsia red, and there are no flowers in the leaf axils. The outside of the rhizome is light yellow, and the inside is scarlet and has a camphor-like scent. The rhizome of turmeric is used as a herbal medicine. It is a yellow medicinal herb with a spicy and bitter taste, and is effective in anti-cancer, Alzheimer's treatment, antioxidant, anti-inflammatory, detoxification, suppressing liver disorders, pain relief, and menstrual irregularities. In India, it is used as a medicine for bruises and sprains and as a spice for curry powder.
이러한 강황(Curcuma longa L.)의 주성분은 커큐민(curcumin), 디메톡시커큐민(demethoxycurcumin), 비스디메톡시커큐민(bisdemethoxycurcumin)과 같은 커큐미노이드(curcuminoid) 색소 성분과 ar-turmerone, curlone, α-turmerone, β-turmerone, bisacumol, zingiberene과 같은 휘발성 정유 성분 및 전분이다.The main components of turmeric (Curcuma longa L.) include curcuminoid pigment components such as curcumin, demethoxycurcumin, and bisdemethoxycurcumin, as well as ar-turmerone, curlone, and α-turmerone. , volatile essential oil components such as β-turmerone, bisacumol, and zingiberene, and starch.
상기 강황추출물은 강황을 60℃에서 건조시킨 후 분쇄기로 분쇄하여 강황 분말을 제조한 후, 상기 강황분말 100중량부에 95%(v/v) 에탄올 300중량부를 가하고 75℃에서 3시간 동안 3회 반복하여 교반하면서 환류추출한 후 여과하고 동결건조한 후 분말화한다.The turmeric extract was prepared by drying turmeric at 60°C and pulverizing it with a grinder to prepare turmeric powder. Then, 300 parts by weight of 95% (v/v) ethanol was added to 100 parts by weight of the turmeric powder, and the mixture was processed three times for 3 hours at 75°C. After reflux extraction with repeated stirring, it is filtered, freeze-dried, and powdered.
해송(Pinus thunbergii)은 소나무과의 상록교목으로 곰솔, 검솔 또는 흑송이라고도 하며, 경상도에서 해송이라고 한다. 높이 50 m, 지름 3-8 m에 달하는 것이 있다. 수피는 검은 회색이며 거북의 등같이 갈라져서 조각으로 떨어진다. 잎은 2개씩 달리고 밑을 아린이 둘러싸고 2-3년간 가지에 달려있다. 해송의 가지의 마디는 풍한 습으로 인한 사지관절마비동통, 굴신불리에 효과가 있고, 타박상, 역절풍(관절염)으로 통증이 지속되는것을 다스리며, 잎은 습진, 옴에 효력이 있으며, 유행성감기, 뇌염의 예방과 치료에 도움이 된다. 수지는 화농 성종기에 소염, 배농 효과가 있으며, 악창, 옴, 가려움증에도 외용하며, 풍습성으로 인한 사지마비와 동통을 치료하는 것으로 알려졌다.Haesong (Pinus thunbergii) is an evergreen tree of the pine family. It is also called black pine, black pine, or black pine. In Gyeongsang-do, it is called haesong. There are some that reach 50 m in height and 3-8 m in diameter. The bark is black-grey and cracks like a turtle's back, falling off into pieces. There are two leaves each, with a ring surrounding the bottom, and they hang on the branches for 2-3 years. The nodes of the branches of the sea pine are effective in treating paralysis of the limbs and joint pain caused by high humidity and indigestion, and treat persistent pain caused by bruises and arthritis. The leaves are effective in treating eczema and scabies, and are effective in treating epidemic colds and encephalitis. It is helpful in prevention and treatment. The resin has an anti-inflammatory and drainage effect on purulent boils, and is also used externally for sores, scabies, and itching, and is known to treat quadriplegia and pain caused by wind damage.
상기 해송껍질추출물은 해송껍질 200g에 70%(v/v) 에탄올 1.2 ℓ를 가하고 5일 동안 침지하여 유효성분을 추출하고 여과한 후 냉각 콘덴서가 장치된 추출기에서 5시간 동안 70~90℃에서 가열하여 농축한 후 분말화한다.The sea pine bark extract was prepared by adding 1.2 liters of 70% (v/v) ethanol to 200 g of sea pine bark, soaking for 5 days to extract the active ingredient, filtering, and heating at 70-90°C for 5 hours in an extractor equipped with a cooling condenser. It is concentrated and then powdered.
상기 글루코사민은 체내에 흡수된 포도당이 천연 합성과정을 거쳐 생성된 아미노산의 일종으로, 관절 조직을 구성하는 중요한 성분인 펠리오글리칸이라는 물질의 생성에 관여하여 연골과 관절의 건강에 영향을 미친다. 따라서 체내에 글루코사민이 많으면 연골 세포를 자극하여 펠리오글리칸이 더 많이 생산되고 그 결과 연골 내에 더욱 많은 수분을 유지하게 함으로써 연골이 퇴화되는 것을 막을 수 있다. 젊을 때에는 글루코사민의 합성과 분해가 균형 있게 이루어지지만 나이가 들면 글루코사민 생성이 현저히 둔화된다. 나이가 들어 계단을 오르내리거나 오래 걸을 때 무릎이나 허리가 아픈 것도 글루코사민의 생성이 줄어들기 때문이다.The glucosamine is a type of amino acid produced through a natural synthesis process from glucose absorbed into the body, and is involved in the production of a substance called pelioglycan, an important component of joint tissue, affecting the health of cartilage and joints. Therefore, if there is a lot of glucosamine in the body, it stimulates cartilage cells to produce more pelioglycan, which in turn prevents cartilage from deteriorating by retaining more moisture in the cartilage. When you are young, glucosamine synthesis and decomposition are balanced, but as you age, glucosamine production slows down significantly. As we get older, our knees and lower back hurt when we go up and down stairs or walk for a long time because the production of glucosamine decreases.
상기 단계 4는 상기 제1 사입 130㎏, 팽화미 100㎏, 물 160㎏ 및 정제효소 150g을 15~16℃에서 3일 동안 발효시켜 제2 사입을 얻는 단계이다. Step 4 is the step of obtaining the second batch by fermenting 130 kg of the first batch, 100 kg of puffed rice, 160 kg of water, and 150 g of purified enzyme at 15-16°C for 3 days.
상기 팽화미는 단계 1에서 제조한 팽화미를 사용한다.The puffed rice used is the puffed rice prepared in Step 1.
상기 단계 4 이후에, 상기 제2 사입 100중량부에 모자반추출물 1~3중량부, 엉겅퀴추출물 1~3중량부 및 참당귀추출물 1~3중량부를 추가적으로 포함할 수 있다.After step 4, 100 parts by weight of the second injection may additionally include 1 to 3 parts by weight of moss extract, 1 to 3 parts by weight of thistle extract, and 1 to 3 parts by weight of angelica root extract.
삭제delete
상기 모자반(Sargassum fulvellum)은 외견상 뿌리, 줄기, 잎의 구분이 뚜렷하고, 뿌리는 가반상이며 1개의 중심 가지를 내어 1~3m 이상 크게 자란다. 줄기는 세모진 기둥 모양 또는 삼각형이고 비틀린다. 잎은 줄기에서 기부 쪽으로 향하여 나며 휘어지고, 주걱 모양 또는 타원형을 하고 잎 중앙부까지 중륵이 생긴다. 상부의 잎은 바소 모양이고 가장자리에 톱니 모양의 돌기가 나며, 온몸에는 줄기로부터 기포가 생긴다. 짙은 황갈색을 하고 한국의 전 해안에서 볼 수 있다. 주요 성분은 알긴산(alginic acid), 클로로필(Chlorophyll a c), β-카로틴(carotene), 푸코잔틴(Fucoxanthin), 라미나린(Laminarin), 만니톨(Mannitol)이며, 모자반을 날 것으로 분석했을 때는 식이섬유와 지방의 양이 아주 낮은 편이지만 분말 형태로 가공한 것을 분석했을 때는 식이섬유와 지방의 양이 30% 이상이나 된다. 모자반은 당질보다는 식이섬유가 상대적으로 많이 함유되어 있는 편이다. 국내에서는 보통 모자반속의 많은 종류가 식용되기도 하며, 알긴산 등 해조 공업의 원료로 이용되거나 비료로도 쓰인다. 알긴산이 위장의 소화작용을 돕고 장운동을 도와주어 변비에 좋고 대장암 예방에 효과가 있다고 한다. 무기질 함량이 많아 고혈압 및 골다공증에 좋고 요오드 함량이 많아서 갑상선기능장애에 좋다.The Sargassum fulvellum has a clear division of roots, stems, and leaves in appearance, has a thorn-shaped root, produces one central branch, and grows taller than 1 to 3 m. The stem is triangular or triangular and twisted. The leaves grow from the stem toward the base, are curved, have a spatula shape or an oval shape, and have a midrib extending to the center of the leaf. The upper leaves are lancet-shaped and have serrated protrusions on the edges, and air bubbles form from the stems all over the body. It has a dark tan color and can be found along the entire coast of Korea. The main ingredients are alginic acid, chlorophyll ac, β-carotene, fucoxanthin, laminarin, and mannitol, and when the raw cap was analyzed, dietary fiber and Although the amount of fat is very low, when analyzed in powder form, the amount of dietary fiber and fat is over 30%. Moatban contains relatively more dietary fiber than carbohydrates. In Korea, many species of the genus Mojas are commonly eaten, and are used as raw materials for the seaweed industry, such as alginic acid, or as fertilizer. It is said that alginic acid aids digestion in the stomach and bowel movement, so it is good for constipation and is effective in preventing colon cancer. It has a high mineral content, so it is good for high blood pressure and osteoporosis, and it has a high iodine content, so it is good for thyroid dysfunction.
상기 모자반추출물은 모자반 100g에 2ℓ의 30%(v/v) 에탄올 수용액에 넣고 25℃에서 24시간 동안 추출하여 제조한다.The above extract is prepared by adding 100 g of moss to 2 liters of 30% (v/v) ethanol aqueous solution and extracting at 25°C for 24 hours.
상기 엉겅퀴(Cirsium japonicum var. maackii (Maxim.) Matsum)는 쌍떡잎식물강 초롱꽃목 국화과의 여러해살이풀로, 가시나물이라고도 하며, 산이나 들에서 주로 자란다. 어린순은 식용으로 쓰이고, 잎, 줄기, 뿌리는 약용으로 이용된다. 특히, 한국의 토종 엉겅퀴는 에스트로겐 수용체(Estrogen receptor)와 결합하는 물질이 존재한다. 구체적으로 형질 전환된 효모균주의 락오페론(Lac operon)을 이용하여 토종 엉겅퀴 추출물에 에스트로겐 수용체와 결합하는 물질이 존재한다는 것을 확인하였고, 그 결합의 수준이 파이토 에스트로겐으로 알려진 퀘르세틴에 준한다는 것을 확인하였다. The above-mentioned thistle (Cirsium japonicum var. maackii (Maxim.) Matsum) is a perennial herb of the dicotyledon class Campanula Asteraceae, also called thornwort, and mainly grows in mountains or fields. The young shoots are used for food, and the leaves, stems, and roots are used for medicinal purposes. In particular, Korea's native thistle contains a substance that binds to the estrogen receptor. Specifically, using the Lac operon of the transformed yeast strain, it was confirmed that a substance that binds to the estrogen receptor was present in the native thistle extract, and the level of binding was confirmed to be comparable to that of quercetin, known as a phytoestrogen.
상기 엉겅퀴추출물은 엉겅퀴 뿌리 100g에 2ℓ의 50%(v/v) 에탄올 수용액에 넣고 35℃에서 24시간 동안 추출하여 제조한다. The thistle extract is prepared by adding 100 g of thistle root to 2 liters of 50% (v/v) ethanol aqueous solution and extracting at 35°C for 24 hours.
당귀는 산형과에 속하는 다년생 초본식물로서, 주로 한국, 일본, 중국 등지에서 약용을 목적으로 재배되고 있다. 당귀는 그 산지에 따라 한국에서 생산되는 참당귀(Angelica gigas Nakai), 일본에서 생산되는 일당귀(Angelica acutiloba Kitagawa), 그리고 중국에서 생산되는 중국당귀(Angelica sinensis Diels)로 구분되고, 그 성분과 약리적 효과는 상이한 것으로 알려져 있다. 예로부터 당귀는 어린 순을 나물로 식용하고, 뿌리를 진통, 항암, 신장 독성경감, 간기능 개선, 당뇨성 고혈압 치료, 혈액순환 개선 등 다양한 질환에 대한 약재로 사용하고 있다. Angelica is a perennial herb plant belonging to the Umbrella family and is mainly cultivated for medicinal purposes in Korea, Japan, and China. Angelica gigas are divided into Angelica gigas Nakai produced in Korea, Angelica acutiloba Kitagawa produced in Japan, and Angelica sinensis Diels produced in China, according to their production area. Their ingredients and pharmacological effects are as follows. is known to be different. Since ancient times, the young shoots of angelica root have been eaten as a vegetable, and the roots have been used as medicine for various diseases such as pain relief, anti-cancer, reduction of kidney toxicity, improvement of liver function, treatment of diabetic high blood pressure, and improvement of blood circulation.
상기 참당귀추출물은 참당귀 뿌리 100g에 2ℓ의 70%(v/v) 에탄올 수용액에 넣고 40℃에서 24시간 동안 추출하여 제조한다.The Angelica root extract is prepared by adding 100 g of Angelica root to 2 liters of 70% (v/v) ethanol aqueous solution and extracting at 40°C for 24 hours.
상기 단계 5는 상기 제2 사입을 100~105℃에서 30~40분 동안 가열하여 한방차를 제조하는 단계이다. Step 5 is a step of manufacturing herbal tea by heating the second batch at 100-105°C for 30-40 minutes.
상기 제2 사입을 100~105℃에서 30~40분 동안 가열함으로써 알콜 성분을 증발시키고 액상의 한방차를 수득할 수 있다.By heating the second injection at 100-105°C for 30-40 minutes, the alcohol component can be evaporated and liquid herbal tea can be obtained.
상기 단계 5 이후에, 상기 한방차 100중량부에 모링가 추출발효물 0.1~1중량부, 저령 추출발효물 0.1~1중량부 및 꾸지뽕청 0.1~1중량부를 추가적으로 포함할 수 있다.After step 5, 100 parts by weight of the herbal tea may additionally include 0.1 to 1 part by weight of fermented Moringa extract, 0.1 to 1 part by weight of fermented extract of low age, and 0.1 to 1 part by weight of kkujippong extract.
상기 한방차에 모링가 추출발효물, 저령 추출발효물 및 꾸지뽕청을 추가적으로 포함함으로써 한방차의 맛을 더욱 향상시킬 수 있는 장점이 있다.There is an advantage in that the taste of the oriental herbal tea can be further improved by additionally including the fermented moringa extract, the fermented extract of the oriental medicine, and the fermented extract of Kujippong.
상기 모링가 추출발효물은 모링가잎 100중량부에 80%(v/v) 에탄올 300~400중량부를 넣고 14~16시간 초음파 추출한 모링가잎 추출액 100중량부에 황국균 1~3중량부를 첨가하고 15~20℃에서 30~32시간 동안 발효시켜 제조한다. The fermented Moringa extract is made by adding 300 to 400 parts by weight of 80% (v/v) ethanol to 100 parts by weight of Moringa leaves and adding 1 to 3 parts by weight of Hwang Guk-gyun to 100 parts by weight of Moringa leaf extract extracted ultrasonically for 14 to 16 hours. It is manufactured by fermenting at 15~20℃ for 30~32 hours.
상기 모링가는 원산지가 인도인 소목이지만, 전세계 어디에서나 재배되고 모링가 나무가 널리 이용되는 많은 지역들에서 귀화되어 야생된다. 모링가과에 속하는 13 종의 모링가 나무가 있으며, 모링가 올레이페라(Moringa oleifera)가 가장 널리 알려져 있다. 모링가 올레이페라는 우산과 같이 펼쳐진 4 내지 8 미터 높이의 관목이다. 30 내지 70 cm 길이의 잎들은 낙엽성이며, 꽃들은 흰색이고 향기가 진하며, 열매는 녹색이고 혁질성 및 현수성의 긴 삼각형상의 긴 깍지로 길이는 30 내지 40 cm에 이르는 특징을 가지며, 인도 북서부 히말라야 산기슭에 자생하고, 열대 전 지역에서 재배하는 다목적 수종의 일종이다. 모링가(Moringa oleifera)는 동남아시아 등에서 자생하는 식물로서 다량의 영양분을 함유하고 있어 기적의 식물로 불리고 있으며, 항당뇨, 항암, 항알러지 등 다양한 효능이 있는 것으로 알려져 있다.The Moringa is a small tree native to India, but it is cultivated all over the world and has become naturalized and wild in many areas where Moringa trees are widely used. There are 13 species of Moringa trees belonging to the Moringaceae family, with Moringa oleifera being the most widely known. Moringa oleifera is a 4 to 8 meter tall shrub that spreads out like an umbrella. The leaves are deciduous, 30 to 70 cm long, the flowers are white and fragrant, and the fruits are green, leathery and pendulous, with long triangular pods reaching 30 to 40 cm in length, grown in the Himalayas of northwestern India. It is a type of multi-purpose tree species that grows naturally at the foot of mountains and is cultivated throughout tropical regions. Moringa (Moringa oleifera) is a plant that grows naturally in Southeast Asia. It contains a large amount of nutrients and is called a miracle plant. It is known to have various effects such as anti-diabetes, anti-cancer, and anti-allergy.
상기 황국균은 우리 전통메주 제조시 일부 자생균으로 부착되어온 균들 중의 일종이지만 일찍부터 일본에서 된장, 간장, 청주 등의 고지제조에 순수분리해서 사용해왔다.The above-mentioned Hwanggukgyun is a type of bacteria that has been attached as a native fungus in the production of traditional Korean meju, but has been used in pure isolation for the production of soybean paste, soy sauce, and Cheongju in Japan since early times.
상기 저령 추출발효물은 저령 100중량부에 70%(v/v) 에탄올 600~700중량부를 넣고 65~70℃에서 24~25시간 동안 추출한 저령 추출액 100중량부에 혼합균 1~3중량부를 첨가하고 15~20℃에서 14~15시간 동안 발효시켜 제조한다. For the low-age extract fermentation product, 600-700 parts by weight of 70% (v/v) ethanol is added to 100 parts by weight of low-age extract, and 1-3 parts by weight of mixed bacteria are added to 100 parts by weight of the low-age extract extracted for 24-25 hours at 65-70°C. It is manufactured by fermenting at 15~20℃ for 14~15 hours.
상기 혼합균은 유산균 60~70중량%, 홍국균 20~30중량% 및 고초균 5~15중량%를 포함한다. The mixed bacteria include 60-70% by weight of lactic acid bacteria, 20-30% by weight of Red Yeast bacteria, and 5-15% by weight of Bacillus subtilis.
상기 저령(Polyporus umbellatus)은 주령, 시령, 저시령, 지오도, 희령, 가저시 등의 이명으로도 불리며, 분류상 담자균류 민주름버섯목 구멍장이버섯과에 속하는 버섯으로, 가을에 활엽수림 내의 특히 오리나무, 참나무, 단풍나무나 떡갈나무 등의 산뿌리에 기생하며 그 성미는 달고 쓰다. 주로 한국, 일본, 유럽, 중국, 미국 등에 분포하며, 자루는 밑동에서 몇 번 갈라지며 갓은 각 가지의 끝에 핀다. 높이는 10~20cm, 지름은 10~30cm이다. 균핵은 불규칙한 괴상으로 생강과 비슷한 것이 많고 표면은 특이한 형태를 보이며 황백색 또는 족제비색이다. 마치 돼지 변과 비슷하여 ‘저령’이란 명칭이 붙었다. 자실체는 복잡하게 가지친 자루와 갓으로 된다. 불규칙한 긴덩어리이거나 원형에 가까운 덩어리로 크기는 고르지 않으며 긴 것은 대개 굽어 있거나 생강처럼 갈라지며 길이 5~25cm이다. 표면은 흑색이거나 흑갈색으로 쭈그러져 있거나 혹은 혹모야의 돌기가 있다. 가볍고 질기며 단면은 유백색이거나 황백색을 띤다. 저령은 수분대사를 원활하게 하는 효능이 있으며, 소변을 잘 보지 못하거나 온몸에 부종이 있을 때 이용하고 임신중에 소변을 잘 보지 못하고 다리가 붓는 증상, 소화기능이 약하여 속이 차고 설사를 하는 증상에 좋다.The above-mentioned Jeoryeong ( Polyporus umbellatus ) is also called by other names such as Juryeong, Siryeong, Jeosiryeong, Geodo, Huiryeong, and Gajeosi. It is a mushroom belonging to the Basidiomycota order Agarumidae family, especially in broad-leaved forests in the fall. It lives on the roots of alders, oaks, maples, and oak trees, and its taste is sweet and bitter. It is mainly distributed in Korea, Japan, Europe, China, and the United States. The stem splits several times at the base, and the cap blooms at the end of each branch. The height is 10~20cm and the diameter is 10~30cm. The sclerotia are irregular, lumpy, similar to ginger, and the surface has a unique shape and is yellow-white or weasel-colored. Because it resembles pig feces, it was given the name ‘Jeoryeong’. The fruiting body consists of complexly branched stalks and caps. It is an irregular long lump or a nearly circular lump of uneven size, and the long ones are usually curved or split like ginger and are 5 to 25 cm long. The surface is black, dark brown, wrinkled, or has lumpy protrusions. It is light and tough, and its cross section is milky white or yellowish white. It has the effect of facilitating water metabolism. It is used when you have difficulty urinating or have swelling all over your body. It is good for symptoms such as difficulty urinating during pregnancy, swelling of the legs, and stomachache and diarrhea due to weak digestive function. .
상기 유산균은 락토바실러스 델브루에키(Lactobacillus delbrueckii), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 브레비스(Lactobacillus brevis), 락토바실러스 아시도필러스(Lactobacillus acidophilus), 페디오코커스 펜토사세우스(Pediococcus pentosaceus), 페디오코커스 세레비세(Pediococcus cerevisiae), 락토코커스 락티스(Lactococcus lactis), 레코노스톡 시트레움(Leuconostoc citreum), 레코노스톡 메센테로이드(Leuconostoc mesenteroides), 비피도박테리움 비피둠(Bifidobacterium bifidum) 및 락토바실러스 람노수스(Lactobacillus rhamnosus)로 이루어진 군에서 선택된 어느 하나를 사용할 수 있다.The lactic acid bacteria include Lactobacillus delbrueckii , Lactobacillus bulgaricus , Lactobacillus casei , Lactobacillus brevis , Lactobacillus acidophilus , and Pedi. Pediococcus pentosaceus, Pediococcus cerevisiae , Lactococcus lactis, Leuconostoc citreum , Leuconostoc mesenteroides , Any one selected from the group consisting of Bifidobacterium bifidum and Lactobacillus rhamnosus can be used.
상기 홍국균은 자낭균문 모나스커스(Monascus)속에 속하는 붉은색의 사상균으로서, 쌀 등과 같은 곡류를 발효시키는 과정에서 각종 유익한 대사산물로 진한 빨간색의 색소 및 모나콜린 K 등을 생산한다. 이 균은 중국을 중심으로 동아시아의 여러 지역에서 천연의 식품 착색제나 가공품 및 소화 촉진과 혈류 개선의 소재로서 오랫동안 사용되어 왔다. 홍국균이 생성하는 2차 대사산물인 메비놀린은 콜레스테롤 생합성효소인 HMG-CoA(3-hydroxy-methyl-3-glutaryl-coenzyme) 환원효소를 강력하게 저해하여 혈중지질 농도를 감소시키고 콜레스테롤 합성을 억제하거나 항진균, 혈당상승의 억제, 혈압조절, 항비만, 항암 등과 같은 각종 기능성을 가진다. 또한, 홍국균은 적색계 색소(rubropuntain, monascorubin)와 황색계 색소(monascin, ankaflavin), 자색계 색소(rubropunctamine, monascorubramine) 등을 생성하며, 이와 같은 색소물질은 항균 및 항암효과가 있다.The red yeast fungus is a red filamentous fungus belonging to the genus Monascus, which produces dark red pigments and monacolin K as various beneficial metabolites during the fermentation process of grains such as rice. This fungus has been used for a long time in various regions of East Asia, especially in China, as a natural food colorant, processed products, and as a material to promote digestion and improve blood flow. Mevinolin, a secondary metabolite produced by Red Yeast fungi, strongly inhibits HMG-CoA (3-hydroxy-methyl-3-glutaryl-coenzyme) reductase, a cholesterol biosynthetic enzyme, to reduce blood lipid concentration and inhibit cholesterol synthesis. It has various functional properties such as antifungal, inhibition of blood sugar rise, blood pressure control, anti-obesity, anti-cancer, etc. In addition, red yeast fungi produce red pigments (rubropuntain, monascorubin), yellow pigments (monascin, ankaflavin), and purple pigments (rubropunctamine, monascorubramine), and these pigment substances have antibacterial and anticancer effects.
상기 홍국균은 모나스커스 필로서스(Monascus pilosus), 모나스커스 러버(Monascus ruber), 모나스커스 퍼프레우스(Monascus purpureus), 모나스커스 카올리앙(Monascus kaoliang), 모나스커스 바리케리(Monascus barykery) 및 모나스커스 안카(Monascus anka)로 이루어진 군에서 선택된 어느 하나를 사용할 수 있다.The red yeast fungi include Monascus pilosus , Monascus ruber , Monascus purpureus , Monascus kaoliang , Monascus barykery , and Monascus Any one selected from the group consisting of Monascus anka can be used.
상기 고초균은 바실러스 섭틸리스(B. subtilis), 바실러스 리크네포르미스(B. lichneformis), 바실러스 메가테리움(B. megaterium), 바실러스 아밀로리퀘파시엔스(B. amyloliquefaciens), 바실러스 낫토(B. natto), 바실러스 안스라시스(B.antharcis), 바실러스렌투스(B.lentus), 바실러스 퍼미러스(B.pumilus), 바실러스 더링지엔시스(B.thuringiensis), 바실러스 알베이(B.alvei), 바실러스 아조토픽산스(B.azotofixans), 바실러스 매세란스(B.macerans), 바실러스 포리믹사(B.polymyxa), 바실러스 파필리에(B.popilliae), 바실러스 코아글란스(B.coagulans), 바실러스 스테아로더모필러스(B.stearothermophilus), 바실러스 파스퇴리(B.pasteurii), 바실러스 패리커스(B.sphaericus) 및 바실러스 패스티디오서스(B.fastidiosus)로 이루어진 군에서 선택된 어느 하나를 사용할 수 있다.The Bacillus subtilis ( B. subtilis ), Bacillus lichneformis ( B. lichneformis ), B. megaterium , B. amyloliquefaciens , Bacillus natto ( B natto ), Bacillus anthracis ( B.antharcis ), B.lentus , B.pumilus , B.thuringiensis , B.alvei ), Bacillus azotopixans ( B.azotofixans ), B.macerans, B.polymyxa , B.polymyxa , B.popilliae , B.coagulans , Bacillus Any one selected from the group consisting of B.stearothermophilus , B.pasteurii , B.sphaericus , and B.fastidiosus can be used.
상기 꾸지뽕청은 꾸지뽕 열매 100중량부에 물 800~900중량부를 가하고 100~105℃에서 4~6시간 동안 추출한 후 50~60℃에서 저온진공 농축하여 70~75Brix의 꾸지뽕 농축액을 제조한 후, 70~75℃에서 25~30분 동안 가열하여 제조한다.The kkujippong extract is prepared by adding 800 to 900 parts by weight of water to 100 parts by weight of kkujippong fruit, extracting it at 100 to 105°C for 4 to 6 hours, and then concentrating in low temperature vacuum at 50 to 60°C to prepare a kkujippong concentrate of 70 to 75 Brix. It is prepared by heating at ~75℃ for 25~30 minutes.
상기 꾸지뽕나무는 뽕나무과의 일부로 꾸지뽕나무에서 자생하는 열매는 음료, 쨈, 고추장 등과 같은 많은 상품으로 사용되고 있고, 꾸지뽕 열매는 가바, 루틴, 플라보노이드, 모르틴 아사파라간산 등 약리적인 물질을 포함하고 있는데, 특히 가바는 신경전달 물질로 불안, 우울, 불면증, 기억력 개선에도 좋은 효과를 볼 수 있으며, 루틴 성분은 모세혈관을 튼튼하게 해주어 당뇨나 혈압에도 좋은 효과가 있는 것으로 알려져 있다.The Cudrania tree is part of the Mulberry family, and the fruits that grow naturally on the Cudrania tree are used in many products such as beverages, jam, and red pepper paste. The Cudrania fruit contains pharmacological substances such as GABA, rutin, flavonoids, and mortin asaparaganic acid. In particular, GABA is a neurotransmitter that is effective in treating anxiety, depression, insomnia, and memory, and rutin strengthens capillaries and is known to be effective in treating diabetes and blood pressure.
본 발명에 따른 가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법은 맛이 우수한 장점이 있다.The method for producing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract according to the present invention has the advantage of excellent taste.
삭제delete
이하, 실시 예를 통하여 본 발명의 구성 및 효과를 더욱 상세히 설명하고자 한다. 이들 실시 예는 오로지 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들 실시 예에 의해 제한되는 것은 아니다. Hereinafter, the configuration and effects of the present invention will be described in more detail through examples. These examples are only for illustrating the present invention and the scope of the present invention is not limited by these examples.
멥쌀 30㎏ 및 물 30㎏을 혼합하여 내부온도가 100℃인 압력가열기에서 10분 동안 가열하고, 15℃ 및 120Pa 압력 하의 진공건조기에서 건조시킨 뒤, 100메쉬로 분쇄하여 팽화미를 제조하였다. 상기 팽화미 30㎏에 물 60ℓ를 가하고 증자기를 이용하여 1.2㎏/㎠, 110℃에서 30분 동안 증자한 후, 백국균(Aspergillus Kawachii) 80g을 가하고 26℃의 항온항습기에서 40시간 동안 배양하여 입국을 제조하였다. 상기 입국 4㎏, 물 6㎏ 및 효모 5g을 25~30℃에서 6일 동안 발효시켜 주모를 제조하였다. 상기 주모 10㎏, 상기 입국 50㎏, 물 70㎏, 가시오가피추출물 1.0㎏, 홍화씨추출물 1.5㎏, 강황추출물 1.0㎏, 해송껍질추출물 1.0㎏ 및 글루코사민 0.5㎏을 23℃에서 6개월 동안 발효시켜 제1 사입을 얻었다. 상기 가시오가피추출물은 가시오가피 10㎏을 함초수 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물을 초임계 추출기의 반응기에 투입하고 CO2 gas를 주입하면서 반응기를 회전시키고, 반응기 내 압력을 60기압으로 유지하면 CO2를 순환시켜 얻은 추출물을 여과하고 동결건조한 후 분말화하여 제조하였다. 상기 함초수는 함초 80중량%, 매실 15중량% 및 오미자 5중량%를 혼합한 혼합물 100중량부에 물 1,000중량부를 가하고 100℃에서 4시간 동안 가열한 후 여과하여 제조하였다. 상기 홍화씨추출물은 홍화씨 10㎏을 구기자추출액 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물 100중량부에 80%(v/v) 에탄올 200중량부를 가하고 4시간씩 3회 환류추출하고 냉침한 후 여과하고 동결건조한 후 분말화하여 제조하였다. 상기 구기자추출액은 구기자 100중량부에 물 300중량부를 가하고 105℃에서 1시간 동안 가열한 후 여과하여 제조하였다. 상기 강황추출물은 강황을 60℃에서 건조시킨 후 분쇄기로 분쇄하여 강황 분말을 제조한 후, 상기 강황분말 100중량부에 95%(v/v) 에탄올 300중량부를 가하고 75℃에서 3시간 동안 3회 반복하여 교반하면서 환류추출한 후 여과하고 동결건조한 후 분말화하여 제조하였다. 상기 해송껍질추출물은 해송껍질 200g에 70%(v/v) 에탄올 1.2 ℓ를 가하고 5일 동안 침지하여 유효성분을 추출하고 여과한 후 냉각 콘덴서가 장치된 추출기에서 5시간 동안 70~90℃에서 가열하여 농축한 후 분말화하여 제조하였다. 상기 제1 사입 130㎏, 팽화미 100㎏, 물 160㎏ 및 정제효소 150g을 15℃에서 3일 동안 발효시켜 제2 사입을 제조하였다. 상기 제2 사입을 100℃에서 40분 동안 가열하여 관절 및 뼈 건강 개선용 한방차를 제조하였다. 30 kg of non-glutinous rice and 30 kg of water were mixed and heated in a pressure heater with an internal temperature of 100°C for 10 minutes, dried in a vacuum dryer at 15°C and 120 Pa pressure, and then ground to 100 mesh to prepare puffed rice. Add 60 liters of water to 30 kg of puffed rice, steam it for 30 minutes at 110°C at 1.2 kg/cm2 using a steamer, add 80 g of Aspergillus Kawachii, and culture in a constant temperature and humidity chamber at 26°C for 40 hours before entering the country. was manufactured. The main seed was prepared by fermenting 4 kg of the above, 6 kg of water, and 5 g of yeast at 25-30°C for 6 days. 10 kg of the above-mentioned hair, 50 kg of the above-mentioned raw material, 70 kg of water, 1.0 kg of Acanthopanax extract, 1.5 kg of safflower seed extract, 1.0 kg of turmeric extract, 1.0 kg of sea pine bark extract, and 0.5 kg of glucosamine were fermented at 23°C for 6 months to make the first batch. got it The Acanthopanax extract is prepared by immersing 10 kg of Acanthopanax in 20 liters of salicornia water for 12 hours, drying and pulverizing the pulverized product, putting the pulverized material into the reactor of a supercritical extractor, rotating the reactor while injecting CO 2 gas, and maintaining the pressure in the reactor. When the pressure was maintained at 60 atmospheres, CO 2 was circulated, and the obtained extract was filtered, freeze-dried, and powdered. The salicornia water was prepared by adding 1,000 parts by weight of water to 100 parts by weight of a mixture of 80% by weight of salicornia, 15% by weight of plum, and 5% by weight of Schisandra chinensis, heated at 100°C for 4 hours, and then filtered. The safflower seed extract was prepared by soaking 10 kg of safflower seeds in 20 liters of goji berry extract for 12 hours, drying and pulverizing, adding 200 parts by weight of 80% (v/v) ethanol to 100 parts by weight of the pulverized material, and extracting under reflux three times for 4 hours each. It was prepared by cold soaking, filtering, freeze-drying, and powdering. The goji berry extract was prepared by adding 300 parts by weight of water to 100 parts by weight of goji berries, heating at 105°C for 1 hour, and then filtering. The turmeric extract was prepared by drying turmeric at 60°C and pulverizing it with a grinder to prepare turmeric powder. Then, 300 parts by weight of 95% (v/v) ethanol was added to 100 parts by weight of the turmeric powder, and the mixture was processed three times for 3 hours at 75°C. It was prepared by refluxing extraction with repeated stirring, filtering, freeze-drying, and powdering. The sea pine bark extract was prepared by adding 1.2 liters of 70% (v/v) ethanol to 200 g of sea pine bark, soaking for 5 days to extract the active ingredient, filtering, and heating at 70-90°C for 5 hours in an extractor equipped with a cooling condenser. It was prepared by concentrating and powdering. The second batch was prepared by fermenting 130 kg of the first batch, 100 kg of puffed rice, 160 kg of water, and 150 g of purified enzyme at 15°C for 3 days. The second batch was heated at 100°C for 40 minutes to prepare herbal tea for improving joint and bone health.
실시예 1에서, 상기 제2 사입 100중량부에 모자반추출물 3중량부, 엉겅퀴추출물 3중량부 및 참당귀추출물 3중량부를 추가적으로 포함한 것을 제외하고 나머지는 동일하게 하여 관절 및 뼈 건강 개선용 한방차를 제조하였다. 상기 모자반추출물은 모자반 100g에 2ℓ의 30%(v/v) 에탄올 수용액에 넣고 25℃에서 24시간 동안 추출하여 제조하였다. 상기 엉겅퀴추출물은 엉겅퀴 뿌리 100g에 2ℓ의 50%(v/v) 에탄올 수용액에 넣고 35℃에서 24시간 동안 추출하여 제조하였다. 상기 참당귀추출물은 참당귀 뿌리 100g에 2ℓ의 70%(v/v) 에탄올 수용액에 넣고 40℃에서 24시간 동안 추출하여 제조하였다.In Example 1, except that 3 parts by weight of moss extract, 3 parts by weight of thistle extract, and 3 parts by weight of angelica root extract were additionally included in 100 parts by weight of the second injection, the rest was kept the same to prepare an herbal tea for improving joint and bone health. Manufactured. The above extract was prepared by placing 100 g of moss in 2 liters of 30% (v/v) ethanol aqueous solution and extracting it at 25°C for 24 hours. The thistle extract was prepared by adding 100 g of thistle roots to 2 liters of 50% (v/v) ethanol aqueous solution and extracting at 35°C for 24 hours. The Angelica root extract was prepared by adding 100 g of Angelica root to 2 liters of 70% (v/v) ethanol aqueous solution and extracting it at 40°C for 24 hours.
[비교예 1][Comparative Example 1]
파쇄한 두메부추 건조물에 100배의 정제수를 넣고 100 ℃에서 4시간 동안 가열한 후 여과하였다. 수득한 액상 추출물을 회전감압농축기로 농축(120 brix)한 후 동결건조기를 이용하여 두메부추 추출물을 수득하였다. 100 times more purified water was added to the dried crushed chives, heated at 100°C for 4 hours, and then filtered. The obtained liquid extract was concentrated (120 brix) using a rotary vacuum concentrator, and then a freeze-dried extract was obtained.
(㎍/㎖)density
(㎍/㎖)
실시예 1에서, 상기 한방차 100중량부에 모링가 추출발효물 1중량부, 저령 추출발효물 1중량부 및 꾸지뽕청 1중량부를 추가적으로 포함한 것을 제외하고 나머지는 동일하게 하여 관절 및 뼈 건강 개선용 한방차를 제조하였다. 상기 모링가 추출발효물은 모링가잎 100중량부에 80%(v/v) 에탄올 300중량부를 넣고 16시간 초음파 추출한 모링가잎 추출액 100중량부에 황국균 3중량부를 첨가하고 20℃에서 30시간 동안 발효시켜 제조하였다. 상기 저령 추출발효물은 저령 100중량부에 70%(v/v) 에탄올 600중량부를 넣고 70℃에서 24시간 동안 추출한 저령 추출액 100중량부에 혼합균 3중량부를 첨가하고 20℃에서 14시간 동안 발효시켜 제조하였다. 상기 혼합균은 유산균 65중량%, 홍국균 25중량% 및 고초균 10중량%를 혼합하여 제조하였다. 상기 꾸지뽕청은 꾸지뽕 열매 100중량부에 물 900중량부를 가하고 100℃에서 4시간 동안 추출한 후 50℃에서 저온진공 농축하여 70Brix의 꾸지뽕 농축액을 제조한 후, 75℃에서 30분 동안 가열하여 제조하였다.In Example 1, 100 parts by weight of the oriental herbal tea was used to improve joint and bone health, except that 1 part by weight of Moringa extract fermentation, 1 part by weight of low-lying extract fermentation, and 1 part by weight of kkujippongcheong were additionally included. Made herbal tea. The fermented Moringa extract was prepared by adding 300 parts by weight of 80% (v/v) ethanol to 100 parts by weight of Moringa leaves, adding 3 parts by weight of Chrysanthemum aureus to 100 parts by weight of Moringa leaf extract extracted by ultrasonication for 16 hours, and fermenting at 20°C for 30 hours. It was manufactured by fermentation. The low-age extract fermentation product is prepared by adding 600 parts by weight of 70% (v/v) ethanol to 100 parts by weight of low-age extract, adding 3 parts by weight of mixed bacteria to 100 parts by weight of low-age extract extracted for 24 hours at 70°C, and fermenting at 20°C for 14 hours. It was manufactured. The mixed bacteria were prepared by mixing 65% by weight of lactic acid bacteria, 25% by weight of Red Yeast bacteria, and 10% by weight of Bacillus subtilis. The kkujippong extract was prepared by adding 900 parts by weight of water to 100 parts by weight of kkujippong fruit, extracting at 100°C for 4 hours, and then concentrating in low temperature vacuum at 50°C to prepare a 70Brix kkujippong concentrate, followed by heating at 75°C for 30 minutes.
[비교예 2][Comparative Example 2]
약콩(쥐눈이콩) 1kg을 정류수를 이용하여 세척한 후, 정류수 8kg과 대형 믹서기를 이용하여 분쇄하였다. 이후 메쉬망을 이용하여 분쇄되지 않은 채 덩어리로 남아있는 약콩 분쇄물을 걸러내고 일정 크기 이내 약콩 분쇄물을 이용하여 고형분 8%를 함유하는 100% 쥐눈이콩 두유를 제조하였다. 100% 쥐눈이콩 두유를 혼합 탱크에 넣은 후, 정제소금 11.3g, 알루로스 283.5g, 스테비오사이드 0.7g, 비타민D 0.7g을 넣은 후 110℃에서 25초간 열처리하여 살균 작업을 수행한 후 냉각시킨 후 대두에서 추출한 이소플라본 입자를 함유하는 캡슐화된 리쏘탄미움 캘카리움(Lithothamium Calcareum) 해초 입자 153.9g을 넣고 충분히 혼합하여 서목태 음료를 제조하였다. 상기 대두에서 추출한 이소플라본 입자를 함유하는 캡슐화된 리쏘탄미움 캘카리움(Lithothamium Calcareum) 입자 제조시에는 대두 이소플라본 입자 13 중량%, 물 26 중량%, 리쏘탄미움 캘카리움(Lithothamium Calcareum) 해초 입자 38 중량%, 아라바아검 2 중량%, 대두 레시틴 8 중량% 및 글리세릴 13중량%를 사용하여 1차 습윤 단계, 2차 습윤 단계, 제2혼합물 형성단계 및 캡슐화 단계를 수행하여 제조하였다.1kg of medicinal beans (snake beans) was washed using distilled water and then ground using 8kg of distilled water and a large blender. Afterwards, the pulverized yakkong that remained in lumps without being pulverized was filtered using a mesh net, and 100% soybean soymilk containing 8% solid content was prepared using the pulverized yakkong within a certain size. After putting 100% soybean milk into the mixing tank, 11.3g of refined salt, 283.5g of allulose, 0.7g of stevioside, and 0.7g of vitamin D were added, sterilization was performed by heat treatment at 110℃ for 25 seconds, and then cooled. Seomoktae beverage was prepared by adding 153.9 g of encapsulated Lithothamium Calcareum seaweed particles containing isoflavone particles extracted from soybeans and mixing thoroughly. When producing encapsulated Lithothamium Calcareum particles containing isoflavone particles extracted from soybeans, 13% by weight of soybean isoflavone particles, 26% by weight of water, and 38% by weight of Lithothamium Calcareum seaweed particles. It was prepared by performing a first wetting step, a second wetting step, a second mixture forming step, and an encapsulation step using 2 wt% arabic gum, 8 wt% soy lecithin, and 13 wt% glyceryl.
[실험예 2][Experimental Example 2]
실시예 1, 3에서 제조한 한방차와 비교예 2에서 제조한 서목태 음료를 관능검사 요원으로 하여금 맛, 향 및 전체적인 기호도와 같은 관능검사를 실시하였다. 측정한 결과를 평균하여 표 2에 나타내었다. 관능검사는 2년 이상 관능검사 경험을 지닌 30명의 관능검사 요원으로 하여금 9점 척도법으로 하여 측정하였다. The oriental herbal tea prepared in Examples 1 and 3 and the Seomoktae beverage prepared in Comparative Example 2 were subjected to sensory tests such as taste, aroma, and overall preference by a sensory tester. The average of the measured results is shown in Table 2. The sensory test was measured using a 9-point scale by 30 sensory testers with more than 2 years of experience in sensory testing.
상기 표 2를 통해 알 수 있는 바와 같이, 비교예 2의 서목태 음료에 비하여 본 발명에 따라 제조된 실시예 1, 3의 한방차가 관능검사의 전체적인 항목에서 높은 점수를 나타내고 있다.As can be seen from Table 2, compared to the Seomoktae beverage of Comparative Example 2, the herbal teas of Examples 1 and 3 prepared according to the present invention showed higher scores in all items of the sensory test.
Claims (5)
상기 입국 4㎏, 물 6㎏ 및 효모 5g을 25~30℃에서 6일 동안 발효시켜 주모를 제조하는 단계(단계 2);
상기 주모 10㎏, 상기 입국 50㎏, 물 70㎏, 가시오가피추출물 1.0㎏, 홍화씨추출물 1.5㎏, 강황추출물 1.0㎏, 해송껍질추출물 1.0㎏ 및 글루코사민 0.5㎏을 22~23℃에서 6개월 동안 발효시켜 제1 사입을 얻는 단계(단계 3);
상기 제1 사입 130㎏, 팽화미 100㎏, 물 160㎏ 및 정제효소 150g을 15~16℃에서 3일 동안 발효시켜 제2 사입을 얻는 단계(단계 4);
상기 제2 사입을 100~105℃에서 30~40분 동안 가열하여 한방차를 제조하는 단계(단계 5); 및
상기 한방차 100중량부에 모링가 추출발효물 0.1~1중량부, 저령 추출발효물 0.1~1중량부 및 꾸지뽕청 0.1~1중량부를 포함하는 단계(단계 6);
를 포함하되,
상기 단계 3에서,
상기 가시오가피추출물은 가시오가피 10㎏을 함초수 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물을 초임계 추출기의 반응기에 투입하고 CO2 gas를 주입하면서 반응기를 회전시키고, 반응기 내 압력을 60기압으로 유지하면서 CO2를 순환시켜 얻은 추출물을 여과하고 동결건조한 후 분말화하여 제조하며,
상기 함초수는 함초 80중량%, 매실 15중량% 및 오미자 5중량%를 혼합한 혼합물 100중량부에 물 1,000중량부를 가하고 100~105℃에서 4~6시간 동안 가열한 후 여과하여 제조하며,
상기 홍화씨추출물은 홍화씨 10㎏을 구기자추출액 20ℓ에 12시간 동안 침지한 후 건조하고 분쇄한 뒤, 상기 분쇄물 100중량부에 80%(v/v) 에탄올 200중량부를 가하고 4시간씩 3회 환류추출하고 냉침한 후 여과하고 동결건조한 후 분말화하여 제조하며,
상기 구기자추출액은 구기자 100중량부에 물 300~400중량부를 가하고 95~105℃에서 1~2시간 동안 가열한 후 여과하여 제조하며,
상기 강황추출물은 강황을 60℃에서 건조시킨 후 분쇄기로 분쇄하여 강황 분말을 제조한 후, 상기 강황분말 100중량부에 95%(v/v) 에탄올 300중량부를 가하고 75℃에서 3시간 동안 3회 반복하여 교반하면서 환류추출한 후 여과하고 동결건조한 후 분말화하여 제조하며,
상기 해송껍질추출물은 해송껍질 200g에 70%(v/v) 에탄올 1.2 ℓ를 가하고 5일 동안 침지하여 유효성분을 추출하고 여과한 후 냉각 콘덴서가 장치된 추출기에서 5시간 동안 70~90℃에서 가열하여 농축한 후 분말화하여 제조하며,
상기 단계 6에서,
상기 모링가 추출발효물은 모링가잎 100중량부에 80%(v/v) 에탄올 300~400중량부를 넣고 14~16시간 초음파 추출한 모링가잎 추출액 100중량부에 황국균 1~3중량부를 첨가하고 15~20℃에서 30~32시간 동안 발효시켜 제조하며,
상기 저령 추출발효물은 저령 100중량부에 70%(v/v) 에탄올 600~700중량부를 넣고 65~70℃에서 24~25시간 동안 추출한 저령 추출액 100중량부에 혼합균 1~3중량부를 첨가하고 15~20℃에서 14~15시간 동안 발효시켜 제조하며,
상기 혼합균은 유산균 60~70중량%, 홍국균 20~30중량% 및 고초균 5~15중량%를 포함하며,
상기 꾸지뽕청은 꾸지뽕 열매 100중량부에 물 800~900중량부를 가하고 100~105℃에서 4~6시간 동안 추출한 후 50~60℃에서 저온진공 농축하여 70~75Brix의 꾸지뽕 농축액을 제조한 후, 70~75℃에서 25~30분 동안 가열하여 제조하는,
가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법.
Add 60 liters of water to 30 kg of puffed rice and steam it for 30 minutes at 110°C at 1.2 kg/cm2 using a steamer, then add 80 g of Aspergillus Kawachii and culture in a constant temperature and humidity chamber at 26°C for 40 hours before entering the country. manufacturing step (step 1);
Producing the main hair by fermenting 4 kg of the rice, 6 kg of water, and 5 g of yeast at 25-30°C for 6 days (step 2);
Prepared by fermenting 10 kg of the above-mentioned hair, 50 kg of the above-mentioned seedlings, 70 kg of water, 1.0 kg of Acanthopanax extract, 1.5 kg of safflower seed extract, 1.0 kg of turmeric extract, 1.0 kg of sea pine bark extract, and 0.5 kg of glucosamine at 22-23°C for 6 months. 1 Obtaining buy-in (step 3);
Obtaining a second batch by fermenting 130 kg of the first batch, 100 kg of puffed rice, 160 kg of water, and 150 g of purified enzyme at 15-16°C for 3 days (step 4);
Preparing oriental medicine tea by heating the second batch at 100-105°C for 30-40 minutes (step 5); and
A step (step 6) of comprising 0.1 to 1 part by weight of Moringa extract fermentation material, 0.1 to 1 part by weight of fermented extract of Jeoryeong, and 0.1 to 1 part by weight of kkujippong extract per 100 parts by weight of the herbal tea;
Including,
In step 3 above,
The Acanthopanax extract is prepared by immersing 10 kg of Acanthopanax in 20 liters of salicornia water for 12 hours, drying and pulverizing the pulverized product, putting the pulverized material into the reactor of a supercritical extractor, rotating the reactor while injecting CO 2 gas, and maintaining the pressure in the reactor. It is manufactured by filtering the extract obtained by circulating CO 2 while maintaining the pressure at 60 atmospheres, lyophilizing it, and powdering it.
The salicornia water is prepared by adding 1,000 parts by weight of water to 100 parts by weight of a mixture of 80% by weight of salicornia, 15% by weight of plum, and 5% by weight of Schisandra chinensis, heated at 100-105°C for 4-6 hours, and then filtered,
The safflower seed extract was prepared by soaking 10 kg of safflower seeds in 20 liters of goji berry extract for 12 hours, drying and pulverizing, adding 200 parts by weight of 80% (v/v) ethanol to 100 parts by weight of the pulverized material, and extracting under reflux three times for 4 hours each. It is manufactured by cold-soaking, filtering, freeze-drying, and powdering.
The goji berry extract is prepared by adding 300 to 400 parts by weight of water to 100 parts by weight of goji berries, heating at 95 to 105°C for 1 to 2 hours, and then filtering.
The turmeric extract was prepared by drying turmeric at 60°C and pulverizing it with a grinder to prepare turmeric powder. Then, 300 parts by weight of 95% (v/v) ethanol was added to 100 parts by weight of the turmeric powder, and the mixture was processed three times for 3 hours at 75°C. It is manufactured by refluxing extraction with repeated stirring, filtering, freeze-drying, and powdering.
The sea pine bark extract was prepared by adding 1.2 liters of 70% (v/v) ethanol to 200 g of sea pine bark, soaking for 5 days to extract the active ingredient, filtering, and heating at 70-90°C for 5 hours in an extractor equipped with a cooling condenser. It is manufactured by concentrating and powdering,
In step 6 above,
The fermented Moringa extract is made by adding 300 to 400 parts by weight of 80% (v/v) ethanol to 100 parts by weight of Moringa leaves and adding 1 to 3 parts by weight of Hwang Guk-gyun to 100 parts by weight of Moringa leaf extract extracted ultrasonically for 14 to 16 hours. It is manufactured by fermenting at 15~20℃ for 30~32 hours.
For the low-age extract fermentation product, 600-700 parts by weight of 70% (v/v) ethanol is added to 100 parts by weight of low-age extract, and 1-3 parts by weight of mixed bacteria are added to 100 parts by weight of the low-age extract extracted for 24-25 hours at 65-70°C. It is manufactured by fermenting at 15~20℃ for 14~15 hours.
The mixed bacteria include 60 to 70% by weight of lactic acid bacteria, 20 to 30% by weight of Red Yeast bacteria, and 5 to 15% by weight of Bacillus subtilis,
The kkujippong extract is prepared by adding 800 to 900 parts by weight of water to 100 parts by weight of kkujippong fruit, extracting it at 100 to 105°C for 4 to 6 hours, and then concentrating in low temperature vacuum at 50 to 60°C to prepare a kkujippong concentrate of 70 to 75 Brix. Manufactured by heating at ~75°C for 25-30 minutes,
Method for producing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract.
상기 팽화미는 멥쌀 30㎏ 및 물 30㎏을 혼합하여 내부온도가 100℃인 압력가열기에서 10분 동안 가열하고, 15℃ 및 120Pa 압력 하의 진공건조기에서 건조시킨 뒤, 100~150메쉬로 분쇄하여 제조하는,
가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법.
The method of claim 1, wherein in step 1,
The puffed rice is manufactured by mixing 30 kg of non-glutinous rice and 30 kg of water, heating it for 10 minutes in a pressure heater with an internal temperature of 100 ° C., drying it in a vacuum dryer at 15 ° C. and 120 Pa pressure, and grinding it to 100 to 150 mesh. ,
Method for producing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract.
상기 단계 4 이후에, 상기 제2 사입 100중량부에 모자반추출물 1~3중량부, 엉겅퀴추출물 1~3중량부 및 참당귀추출물 1~3중량부를 추가적으로 포함하되,
상기 모자반추출물은 모자반 100g에 2ℓ의 30%(v/v) 에탄올 수용액에 넣고 25℃에서 24시간 동안 추출하여 제조하며,
상기 엉겅퀴추출물은 엉겅퀴 뿌리 100g에 2ℓ의 50%(v/v) 에탄올 수용액에 넣고 35℃에서 24시간 동안 추출하여 제조하며,
상기 참당귀추출물은 참당귀 뿌리 100g에 2ℓ의 70%(v/v) 에탄올 수용액에 넣고 40℃에서 24시간 동안 추출하여 제조하는,
가시오가피추출물, 홍화씨추출물, 강황추출물 및 해송껍질추출물을 포함하는 한방차의 제조방법.
According to clause 1,
After step 4, 100 parts by weight of the second injection additionally includes 1 to 3 parts by weight of moss extract, 1 to 3 parts by weight of thistle extract, and 1 to 3 parts by weight of angelica root extract,
The above moss extract is prepared by adding 100 g of moss in 2 liters of 30% (v/v) ethanol aqueous solution and extracting at 25°C for 24 hours,
The thistle extract is prepared by adding 100 g of thistle root to 2 liters of 50% (v/v) ethanol aqueous solution and extracting at 35°C for 24 hours,
The Angelica root extract is prepared by adding 100 g of Angelica root to 2 liters of 70% (v/v) ethanol aqueous solution and extracting at 40°C for 24 hours.
Method for producing oriental herbal tea containing acanthophyllum extract, safflower seed extract, turmeric extract, and sea pine bark extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210066909A KR102640760B1 (en) | 2021-05-25 | 2021-05-25 | Manufacturing method of Medical Herb Tea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210066909A KR102640760B1 (en) | 2021-05-25 | 2021-05-25 | Manufacturing method of Medical Herb Tea |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220159532A KR20220159532A (en) | 2022-12-05 |
KR102640760B1 true KR102640760B1 (en) | 2024-02-28 |
Family
ID=84391857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210066909A KR102640760B1 (en) | 2021-05-25 | 2021-05-25 | Manufacturing method of Medical Herb Tea |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102640760B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010046562A (en) * | 1999-11-12 | 2001-06-15 | 박명환 | Composition for treatment of osteoarthritis |
KR100391511B1 (en) * | 2000-11-06 | 2003-07-16 | 삼보종합식품 주식회사 | Method For Producing Refined Rice Wine Made From Swelled Rice |
KR100591164B1 (en) * | 2004-11-08 | 2006-06-19 | 주식회사 켐온 | Herbal extract for prophylaxis or treatment of inflammatory diseases and process for preparation thereof |
KR102495188B1 (en) | 2019-11-05 | 2023-02-03 | 농업회사법인 주식회사 삼원네이처 | A composition for immune enhancement and bone health comprising allium senescens l extract |
-
2021
- 2021-05-25 KR KR1020210066909A patent/KR102640760B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20220159532A (en) | 2022-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hashim | Centella asiatica in food and beverage applications and its potential antioxidant and neuroprotective effect. | |
KR101332321B1 (en) | Health food fermented using effective micro-organisms with herbal medicine and manufacturing method thereof | |
KR100375370B1 (en) | Herb coffee of manufacture method | |
KR20080090806A (en) | Cosmetic composition containing natural product extracts for restoring skin condition | |
KR20110056905A (en) | Composition of mixed herb medicine for leached tea | |
KR20130104692A (en) | Composition foranti-obesity using extract of crataegi fructus | |
KR101166883B1 (en) | Composition of mixed herb medicine for leached tea | |
KR102501735B1 (en) | The methods of manufacture of functional fermented mixture extracts containing sprouts, vegetable biopharmaceuticals and red ginseng | |
KR20110056903A (en) | Composition of mixed herb medicine for leached tea | |
KR102614938B1 (en) | Composition containing rice bran fermented with lactic acid bacteria as a main component and method for producing the same | |
KR101163564B1 (en) | Manufacturing method of soybean paste and soybean paste manufactured thereby | |
KR20110080817A (en) | The healthy beverage manufactacturing method | |
KR102640760B1 (en) | Manufacturing method of Medical Herb Tea | |
CN105124526A (en) | Soybean sauce prepared from radix polygonati officinalis, donkey meat and folium ginkgo and preparing method of soybean sauce | |
CN107375982A (en) | A kind of air freshener for being applicable northern house | |
WO2013133217A1 (en) | Glucose uptake promoter | |
KR101375347B1 (en) | The method for manufacuting red ginseng drink with medicinal herb, and the red ginseng drink made by the method | |
KR20220063978A (en) | Production method of fermented ussuri thistle and Pineleaf, garlic,Liliaceae butterbur, Chaenomelessinensis (Thouin)Koehne, Punicagranatum, Cynanchumwilfordii, Dandelion, ginkgo using Pineapple | |
CN106212783A (en) | Organic tea Pueraria lobata leaf potato leaf formula black tea | |
KR20110003186A (en) | Powder manufacturing process using rind and pip of rubus coreanus | |
KR101756273B1 (en) | A method for manufacturing health-promoting sphere and extract using herbal materials | |
KR102673766B1 (en) | Manufacturing method of Medical Herb Tea | |
KR20070107213A (en) | A mugwort tea composition made from mugwort and a mugwort tea??bag using the methods | |
Ashok et al. | Underutilized leafy vegetables of India and their pharmaceutical value to provoke human immune system | |
KR102640050B1 (en) | Manufacturing method of Medical Herb Tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |